|
|
||
|
Hearing summary11th October 1999
The Bristol Royal Infirmary Inquiry oral hearings this week focus on concerns raised about the adequacy of paediatric cardiac surgery at the Bristol Royal Infirmary (BRI) and the subject of medical and clinical audit.
Today the Inquiry heard firstly from Professor Marc de Leval, Professor of Cardiothoracic Surgery, University of London. He was followed by Dr Stewart Hunter, Consultant Paediatric Cardiologist, Freeman Hospital, Newcastle Upon Tyne.
They described the visit they made, at the request of the management of the United Bristol Healthcare NHS Trust (UBHT), to the BRI in February 1995. The two doctors were asked to review the paediatric cardiothoracic surgery unit at the hospital and to draw conclusions about concerns which had been raised relating to above average mortality and morbidity figures for babies and children undergoing cardiothoracic surgery. Professor de Leval described the timetable of the visit and the information which was presented to him and Dr Hunter. They both concluded by commenting on their draft report and subsequent alterations made to that report, which was then presented to UBHT. |
||
FULL TRANSCRIPT
1 Day 60, 11th October 1999 2 (10.45 am) 3 MISS GREY: Good morning, sir. 4 THE CHAIRMAN: Good morning, Miss Grey. Good morning, 5 everyone. I apologise that we are beginning slightly 6 later than we should and that we announced but there are 7 still, as regards those who travel from London, 8 travelling difficulties which one hopes will correct 9 themselves by the end of this week. 10 May I also, while I am talking, Miss Grey, refer 11 back to the letter which I mentioned I had received last 12 week from the Permanent Secretary of the Department of 13 Health. As it was addressed to me, I sought the 14 Permanent Secretary's authority to make the letter 15 public and this has been readily agreed so that letter 16 will now be scanned into the public record. 17 Miss Grey? 18 MISS GREY: Sir, this morning we have the benefit of hearing 19 again from Professor de Leval, who on this occasion will 20 be giving evidence to the Inquiry of his investigation 21 into the Paediatric Cardiac Surgery Unit there. So can 22 I invite him to come forward and take the stand, 23 please? 24 Could you stand, please, Professor, to take the 25 oath? 0001 1 PROFESSOR MARC DE LEVAL (SWORN): 2 Examined by MISS GREY: 3 Q. Professor, you have provided to the Inquiry a witness 4 statement on this issue which can be found at WIT 319, 5 please, page 1. 6 Is that the first page of your witness statement 7 on this issue? 8 A. That is correct. 9 Q. If we turn, please, to page 5, is that your signature on 10 the bottom? 11 A. Yes, it is. 12 Q. Are the contents of this statement true to the best of 13 your knowledge and belief? 14 A. Yes, they are. 15 Q. If we turn to one of the appendices to this witness 16 statement, page 13, please, can you just explain to the 17 Inquiry how these notes were generated and whether they 18 are yours or that of your colleague, Mr Hunter? 19 A. Those are the notes from Dr Hunter, so he had taken the 20 handwritten notes and had them typed and sent to me so 21 that we can use our notes to write the report. 22 Q. We can see at the top there is a fax date of 23 23rd February 1995. 24 A. Yes. 25 Q. That is when they were sent through by Dr Hunter to you; 0002 1 is that right? 2 A. The fax, that is right, yes. 3 Q. If we could start, please, by looking at UBHT 212/40, 4 just as a matter of record, really, Professor, can we 5 confirm, this is a letter sent by you to Mr Dhasmana 6 which marked the beginning of your work on human factors 7 in the switch operation, did it not, when you were 8 obtaining the co-operation of colleagues in different 9 units to participate in the study that you were planning 10 at that stage? 11 Do you want to scroll up through the letter? 12 A. I would like to read it, because I forgot about this 13 letter. (Pause). This is a letter which had been sent 14 to all the cardiac surgeons in the UK to ask their 15 participation to my study on the arterial switch 16 operation which was being initiated at that particular 17 time, that is correct. 18 Q. Again, I think it is correct, is it not, that 19 Mr Dhasmana agreed to participate in the study? 20 A. He did, yes. 21 Q. And to submit data from his switch series as part of it? 22 A. He did, yes. 23 Q. I think in the event, because of the cessation of the 24 switch programme, he sent to you only details of two 25 operations that fell within your terms of reference and 0003 1 the ongoing prospective participation fell to the part 2 of Mr Pawade; is that correct? 3 A. I cannot answer the question because the study was 4 confidential, so I am myself unaware who sent data. The 5 only thing I can say is that Mr Dhasmana discontinued 6 his switch operation in early 1995, and therefore 7 I expect that there were no patients of his in that 8 survey. 9 Q. If we go on then, please, to UBHT 61/337, this is the 10 letter -- if we can scroll up a little further, 11 please -- from Mr Wisheart to yourself? 12 A. Yes. 13 Q. First asking you to conduct an investigation into the 14 field of paediatric cardiac surgery in the unit. Can 15 I ask you, did he contact you solely by letter, or was 16 there any conversation by phone between yourselves? 17 A. No, I believe he phoned me to find out whether I would 18 accept it, and then he put it in writing. 19 Q. Did he describe to you at that stage the nature of the 20 investigation? 21 A. No. 22 Q. So when you received this letter, you knew no more than 23 is set out in this letter? 24 A. That is correct, yes. Actually, the first information 25 we had is when we met with the Chief Executive that 0004 1 particular day. 2 Q. It is right that by that time Dr Hunter had been 3 appointed as a paediatric cardiologist to assist you 4 with this investigation? 5 A. Yes. I believe he received a letter about a week later. 6 Q. We can look at that if we look at JDW 3/312, please. 7 There is the date, 30th January, at the top, and it is 8 in effect, is it not, a repetition of the letter to 9 yourself, save that it adds the information that 10 Professor Marc de Leval has already agreed to act in 11 this matter? 12 A. I have not seen that before. 13 Q. It may be that the Inquiry will hear from Dr Doyle of 14 the Department of Health who was, you may recollect, the 15 clinician who had been contacted at the Department of 16 Health, the Medical Officer, by certain persons in the 17 Trust and who had therefore been concerned in events at 18 this stage, that he thought it would have been helpful 19 to have included a statistician in your investigating 20 team, if I may call it that. 21 Do you think that would have been a helpful 22 addition to your team? 23 A. Yes. I think that the lack of statistician is 24 a deficiency of the report. There is more than that. 25 I think that first of all the data we were presented 0005 1 with were deficient themselves, and I think that 2 a statistician is as good as the data you provide to the 3 statistician. I think that the deficiency was the 4 weakness of the data and the pressure of time which just 5 made it impossible to have good data. I do not disagree 6 that a statistician would have been much more demanding 7 than we were to produce a report, and any competent 8 statistician would have simply refused to comment on 9 this, I think. 10 Q. You mentioned there another pressure, the pressure of 11 time constraints. 12 Can you explain to us briefly what those were? 13 A. When I was invited to go to Bristol, I indicated that 14 I could do it after a holiday which I had booked the 15 following month, and if they wanted me to come before, 16 I could only spend a day to do so, and they opted for 17 that proposal. 18 Q. So that was the impetus which lay behind the time of 19 a visit on 10th February? 20 A. Yes, so there was a timing in terms of they wanted to 21 have someone coming very soon, then the time we spent 22 was, I think, short, and furthermore, they wanted 23 a report rapidly following the visit, which also made 24 a lot of pressure. 25 Q. Because your holiday had been pre-booked before you were 0006 1 even invited to carry out this study? 2 A. That is correct. 3 Q. If we look, please, at UBHT 61/355, that is a timetable 4 of your visit. 5 First of all, if we scroll it down briefly, can we 6 confirm that timetable conforms roughly to what in fact 7 took place, that you saw the various individuals set out 8 in that timetable? 9 A. Yes. The only thing I think is that the afternoon 10 session was to take place I think at the Children's 11 Hospital, but we stayed in the Royal Infirmary, we did 12 not go to the Children's Hospital. 13 Q. At that stage I think you met Dr Hughes and 14 Mr Barrington, but were you joined in your discussions 15 by Dr Martin, Dr Hayes and Mr Dhasmana? 16 A. Yes, we saw all of them, yes. 17 Q. If we scroll up, please, again to the top of that 18 timetable, we see there that you were scheduled to meet 19 with Mr Dhasmana and Mr Wisheart initially, and then 20 that you would be joined by Dr Martin and Dr Hayes, two 21 consultant cardiologists. 22 Do you think, perhaps with the benefit of 23 hindsight, that it was suitable that your meeting with 24 Mr Wisheart would have been joined by the cardiologists 25 rather than with you being given an opportunity to see 0007 1 the cardiologists separately? 2 A. I suppose that it is always useful to see people 3 individually. We could also argue it would perhaps have 4 been better to see Mr Dhasmana and Mr Wisheart 5 individually, and then see them together. I think that 6 the reason for our visit was very surgically oriented 7 and I think complaints had been made about surgical 8 results. I think that we probably made the error of not 9 trying to see individual members of all the team as 10 well, I suppose. 11 Q. You talk about that as being an "error" at least with 12 the benefit of hindsight. Did you get an impression at 13 the time that the frankness of any discussions was 14 impeded by the presence of other people in the room at 15 any time? 16 A. I think the meeting was quite open. Again, if 17 I recollect it correctly, I suspect that we could have 18 asked cardiologists specific questions about individual 19 surgeons, for example, which we probably did not do at 20 the time, although, as we discussed later, the surgeons 21 themselves had provided data where they had 22 individualised the surgeons. But it would have been 23 useful to discuss with the cardiologists on the one 24 hand, and similarly, it could have been useful to 25 discuss with the surgeons the performance of the 0008 1 cardiologists. 2 Q. As it was, did you have an opportunity to discuss either 3 issue with either group? 4 A. We did not discuss it specifically, but when we looked 5 at the data, for example, the switch operations, 6 a number of those patients had incomplete diagnosis or 7 insufficient diagnosis, and if my memory is correct, 8 I think one patient had an undiagnosed coarctation of 9 the aorta, for example, so we did not specifically ask 10 the surgeons what kind of service they had from the 11 cardiologists, but from the data we received, it was 12 evident that there were some weaknesses there as well. 13 Q. And just to clarify, I think you implied earlier that 14 you did not or were not able to ask the surgeons what 15 input the cardiologists were making into post-operative 16 care? 17 A. No, but when we discussed the post-operative management 18 of the patient it was quite clear that there was a great 19 deal of disorganisation and lack of support between the 20 various teams; and the cardiologists were not based 21 where the operations took place. I think that their 22 input into the post-operative management was 23 insufficient. 24 Q. Just perhaps for the sake of the record, Chairman, we 25 might note the covering letter, please, at page 354, the 0009 1 covering letter for this programme, where we see the 2 circulation list. One notes that it is not directly 3 addressed but is copied to Professor Vann Jones, and 4 furthermore, that Dr Joffe is not on the direct 5 circulation list either. 6 You did not meet with Dr Joffe during the course 7 of the visit? 8 A. No. I think he was out of town and he did apologise, 9 I think, because he could not be there. He had 10 a commitment the day we were there he could not cancel, 11 I think. 12 Q. If we go, then, to your report, the first version of the 13 report, if I may call it that, appears at UBHT 52/262. 14 This is the fax that sent the version through. It was 15 addressed at that stage to Dr Roylance. 16 Firstly, can I just ask you: how was the report 17 prepared between yourself and Dr Hunter? 18 A. The agreement was that I would summarise or have my 19 notes taken in the meeting typed before I went on 20 holiday, which I did. My secretary sent that to 21 Dr Hunter while I was away. Then Dr Hunter sent his own 22 comments and I believe a draft report and I sent him 23 mine when I came back from my holiday and we realised 24 that they were very, very similar, so we agreed that 25 I would make some amendments to my report using his own 0010 1 report. This is the way it was done. 2 So that particular report was sent by my Secretary 3 but it had been seen, obviously, by Dr Hunter who had 4 agreed with the amendments I had made. 5 Q. If we look at page 266 of the report, we can see there 6 the summary of the data that was displayed during the 7 meeting. 8 First of all, can I ask you, did you receive any 9 data in advance of arrival at the UBHT? 10 A. No. I had no data. 11 Q. So you were required to assimilate the data during the 12 course of the meetings and thereafter? 13 A. Yes. 14 Q. You speak first of all as to data produced by 15 Dr Bolsin. Can I ask you first to look, please, just 16 for the sake of identifying that data, at UBHT 61/80. 17 Firstly, do you recognise this cover sheet? 18 A. Yes. 19 Q. That was part of the material given to you by Dr Bolsin; 20 is that correct? 21 A. Yes, that is correct, yes. 22 Q. So if we turn over the page, page 81, that would be, 23 again, part of the material that was presented. 24 Page 82: similar. 25 A. Yes. 0011 1 Q. Pages 83, 84, 85, 86. 2 Do you recognise page 87? 3 A. I do not recognise that page, no. I thought that the 4 only data where surgeons had been individualised had 5 been the data set produced by the surgeons themselves, 6 so I do not recall this, having received it. I do not 7 recall this. 8 Q. So presumably the same comment would apply if we went 9 over the page to page 88? 10 A. Yes, the same comment. 11 Q. If we can go please now to GMC 16/35, do you recognise 12 this as being material provided to you? 13 A. Yes. 14 Q. If we go over the page and rotate, was the remainder of 15 the data presented in this sort of format? 16 A. We had the detail for the 13 switches -- are there 13 17 switches? 18 Q. I think that is correct, yes. 19 A. Yes. We received that. Actually, we received the 20 details of those 13 switches I think from both Dr Bolsin 21 and from the surgeons. 22 Q. I think this may be data of more than 13 switches here. 23 A. We record the details of 13 switches, but not of the 24 whole series, which was more than 13. 25 Q. Dr Bolsin may say that he also gave to you data from an 0012 1 annual report produced from within the unit in 1990 to 2 1991. Do you have any recollection of any further data? 3 A. I have no recollection. I do not have them in my file, 4 that is for sure, no. 5 Q. And you have taken away the remainder of the data that 6 he gave to you, have you? 7 A. I thought I did, yes. 8 Q. So the remaining material that I showed to you earlier 9 is consistent with what you have in your file; is that 10 correct? 11 A. Yes, except for the surgeons being individualised. 12 There are two tables. I do not have data. 13 Q. That is the material you said you did not recognise? 14 A. That is right. 15 Q. If we go back, then, please, to page 266, you say in the 16 second paragraph there that the second set of data was 17 received from the cardiac surgeons and it may well be -- 18 were you told this -- that the cardiologists had 19 participated in its preparation as well? 20 A. I forgot the detail. What I know is that that had been 21 done within a few days or the week which preceded our 22 visit. I forgot who contributed to this. 23 Q. That data covered the period from January 1992 to 24 January 1995, a three-year period? 25 A. Yes. 0013 1 Q. Was that what you had asked for in advance of the 2 meetings? 3 A. We had not asked any data beforehand. 4 Q. So this was their initiative? 5 A. Their initiative, yes. 6 Q. And Mr Wisheart, I think, may say that it was on his 7 initiative that the data had been broken down into 8 a surgeon-specific form. Can you comment on that? 9 A. I cannot. I mean, what I certainly said afterwards is 10 that I congratulated the surgeons for having done that, 11 and particularly Mr Wisheart, because obviously his 12 results in particular for the AV canals was much worse 13 than Mr Dhasmana's, and I thought it was very fair of 14 him to do that. 15 Q. In any event, if he says that it was produced on his 16 initiative, it is certainly the case that it was not 17 produced in response to a request from you -- 18 A. It was not, no. 19 Q. -- and it therefore came in excess, as it were, of such 20 a situation? 21 A. As I said, we had no request because we did not know 22 what the exact reason for the visit was. We knew there 23 was a problem about results, but this is all we knew. 24 Q. You received data from the surgeons in your visit with 25 them, and data from Dr Bolsin later on during the day, 0014 1 because you saw him later; is that correct? 2 A. I forgot the timing. 3 Q. We can go back to the programme at UBHT 61/355. If we 4 scroll down a little ... (Pause). 5 A. Yes, we received this afterwards, yes. 6 Q. Does it follow you were not able to discuss Dr Bolsin's 7 data with the surgeons? 8 A. We had, at the end of the day, a meeting where the 9 surgeons and Dr Bolsin was there, so this is not exactly 10 what the list of participants is. I am pretty sure at 11 the end of the meeting where the surgeons and Dr Bolsin 12 were present -- my recollection, I think, is based on 13 the fact that we discussed the meeting which took place 14 the night before the last switch was operated, and I am 15 convinced that between that discussion the surgeons and 16 Dr Bolsin were present. 17 Q. Was there any discussion of Dr Bolsin's tabulation of 18 data during that meeting that you can recollect? 19 A. I do not recollect it, no. 20 Q. One thing that appears from the data we have seen 21 briefly is that with the exception of the switch 22 operation data, which was common to both data sets, 23 there appears to be little overlap in the time-scale of 24 the two sets of data? 25 A. That is correct, yes. 0015 1 Q. If we look at page 269 -- this is UBHT 52/269 -- this is 2 the sole table I think that is appended to your report? 3 A. Yes. 4 Q. It deals with January 1992 to January 1995. Is it 5 based, therefore, on the data you received from the 6 surgeons? 7 A. That is correct. Obviously we had no certainty that 8 either set of data had been validated. We thought that 9 it was important to have the data where surgeons had 10 been individualised, and this is, I presume now, the 11 reason for having used those data to comment on. 12 Q. Did you make any use of Dr Bolsin's data in the event, 13 then? 14 A. I do not recollect whether we had used them or if -- 15 I do not think I can comment on this. Obviously we 16 discussed those data with Dr Hunter, but whether we 17 considered making two different tables with two sets of 18 results, I have forgotten that. 19 Q. One of the comments that you make in your witness 20 statement is you say: 21 "With hindsight, one could argue that it was 22 unwise to produce a report based on such weak data." 23 Can you summarise what you mean by "weak data"? 24 A. I think that the data had not been validated. I think 25 that at least the data that the surgeons had collected 0016 1 had been collected not prospectively; they went back to 2 all the records, I presume, and we had no guarantee that 3 some data had not been missed. 4 We had no valid data to be compared with. I think 5 the UK register itself is not validated; it does not 6 individualise institutions or surgeons. And I think 7 that any statistician would be very reluctant to draw 8 firm conclusions from that type of analysis. 9 Q. I think it would be a fair supposition that you 10 appreciated those data weaknesses at the time of 11 producing the report? 12 A. Certainly, yes. 13 Q. What were the factors, then, that led the report to be 14 produced nonetheless? 15 A. The report was produced as a confidential document to 16 the Chief Executive which had been our brief by the 17 Chief Executive when we met him. Unfortunately, the 18 document became part of the public domain before the 19 Chief Executive could see it, which was obviously not 20 our intention, not expected. I think that if I had 21 known that the document was going to be part of the 22 public domain, I would have been more careful in the 23 wording of the document. I think that it is totally 24 unfair to say that a surgeon is a high risk surgeon with 25 that type of data, and I think that it was irresponsible 0017 1 to say that with the data we had. 2 Q. We will come on to that, if we may, in more detail, but 3 I think it would be perhaps fair to summarise your 4 report as saying that the reason why it was thought that 5 it was acceptable to base it on data that was known to 6 be weak was that it was intended merely as 7 a confidential report to the Chief Executive? 8 A. That is correct. 9 Q. And perhaps I might add, one to be produced within 10 a short time-scale? 11 A. That is correct, yes. 12 Q. Can we go then, please, to the meetings which you had on 13 10th February, and firstly to the meeting with 14 Dr Roylance as the first meeting which you had that day. 15 Can you tell us, please, what the brief that 16 Dr Roylance gave to you was to the extent that you have 17 not covered it already? 18 A. He first alluded to the difficulty of Mr Wisheart's 19 position being on the one hand investigated in this 20 particular problem, and at the same time, being Medical 21 Director, at the time and implied that he wanted to have 22 the report sent to him rather than the Medical Director 23 for that particular reason. 24 He explained to us that there had been complaints 25 about the results of cardiac surgery and that he wanted 0018 1 to have an outside opinion, which was the reason for our 2 visit, and asked again that report to be issued with the 3 shortest possible delay, because of time, the pressure. 4 Q. Did he say who would see the report? 5 A. No. He asked the report to be sent to him, again, 6 rather than the Clinical Director. My understanding is 7 that the report would have been discussed by the Chief 8 Executive with the different parties involved in cardiac 9 surgery. 10 Q. You say that he mentioned that there had been complaints 11 about paediatric cardiac surgery. Did he give you any 12 indication as to the nature of those complaints or how 13 widely touched the unit was by such complaints? 14 A. First of all, I am not sure he used the word 15 "complaints", but it was what he meant. No, we did not 16 know. We understood what the problem was, or started to 17 have some idea what it was, when we received the 18 calendar of events from Dr Bolsin. We started to have 19 an idea of what the problem had been. Obviously the 20 surgeons we saw first mentioned Dr Bolsin, but Dr Bolsin 21 is the one who gave us the details of what had happened 22 since 1989. 23 Q. Dr Roylance may say that what he intended or put across 24 to you when he met you and Dr Hunter was that firstly 25 what might be described as a "quick and dirty" review 0019 1 was needed. Is that a phrase that you can recollect 2 being used? 3 A. I do not recollect the phrase, but he may have used it. 4 Q. The sense of it: is that consistent with what you 5 understood to be required? 6 A. What we understood is that they wanted to have an 7 outside opinion on the results so that they could go 8 further in trying to solve the problems they were 9 facing. 10 Q. So because it was to be quick, it would not need to be 11 unduly refined? 12 A. Well, it is not because it is quick; the quality should 13 have been good. I think that the time pressure did not 14 allow us to, you know, request more investigations or to 15 spend more time on it, but I think that the quality of 16 the report was as good as we thought it could be 17 following the information we had received. 18 Q. Did he specifically ask for your opinion on three 19 issues: the appointment of a new paediatric cardiac 20 surgeon; the move up the hill to the Children's 21 Hospital; and the issue of what interim surgery could be 22 permitted to take place until Mr Pawade took up his post 23 in May 1995? 24 A. He did not ask us our opinion about a decision which had 25 already been made, so the decision to concentrate the 0020 1 paediatric work on one site had been made. Mr Pawade 2 had been appointed. The switch programme had been 3 discontinued already when we went there. I think that 4 there had been a directive from the Department of Health 5 which was I think even wider than just the switch, if 6 I am correct. 7 So all these decisions had been taken already when 8 we visited there, so we are not part of those decisions. 9 Q. The fault is mine for phrasing my question badly. The 10 question was whether Dr Roylance was asking for your 11 opinion as to the adequacy of those steps to address any 12 problems within paediatric cardiac surgery? 13 A. No, he indicated that those steps had been taken and 14 I suppose that he implied that he wanted to find out if 15 we thought it was satisfactory in view of the problems 16 we had been asked to give an opinion on. 17 Q. If we turn, please, to WIT 319/13, these are Dr Hunter's 18 notes of the meeting with Dr Roylance, amongst others. 19 What is said there in the second line, is that 20 Dr Roylance stated his concerns about the service -- 21 I think we have covered that, have we, on what he 22 indicated were his concerns about the service? What did 23 he say about that? 24 A. The service is, I understood, the results of paediatric 25 cardiac surgery. Whether he implied it includes in the 0021 1 service the actual facilities, I cannot comment on what 2 he meant at the time. 3 Q. But he stated some concerns about the service or its 4 results? 5 A. Yes. 6 Q. The note then goes on to say he had stated also some 7 concerns about professional loyalty in some members of 8 staff involved in the dispute. 9 What can you recollect about that? 10 A. It is a question Dr Hunter maybe can answer better than 11 me because it is his note. Whether he implied the 12 conflicts between Dr Bolsin and the surgeons, I am not 13 sure. I do not know if the words "professional loyalty" 14 refer to Dr Bolsin or to the surgeons, I must say. That 15 is quite vague to me and I just cannot comment on that. 16 Q. Can you recollect any discussion of the professional 17 loyalties of any member of staff? 18 A. I do not recollect, but it does not mean it has not been 19 mentioned; I do not recollect it. 20 Q. Dr Bolsin for his part may have a concern that whatever 21 briefing was given to you by Dr Roylance in some way 22 influenced you, or possibly biased you, against him and 23 his audit before you saw him, Dr Bolsin. 24 A. That may be true. I am not sure. I do not think that 25 it did influence us too much, or at all. I think that 0022 1 Dr Bolsin's interview and presentation was quite clear 2 and he had the facts. I do not think that we could 3 argue against or for what he had done, so I do not think 4 that we had been influenced by what had been said in 5 Dr Roylance's office in our report. 6 Q. To put it crudely, Professor de Leval, can you remember 7 any anti-Dr Bolsin "spin", as it were, on anything that 8 Dr Roylance said to you? 9 A. I do not think so. No, I do not recollect any comment. 10 Q. Going on, you next met -- we see here you were joined by 11 Mrs Ferris; is that correct? 12 A. I must say, I have forgotten this. 13 Q. There was, in any event, an outline of the changes that 14 were to be put in hand in the service? 15 A. I do not recall Mrs Ferris having joined him. I am sure 16 she did, but I do not recall certainly what her 17 contribution to that meeting was. 18 Q. Turning over the page, we come to the first discussion 19 with Mr Wisheart and Mr Dhasmana. We see there that in 20 particular you reviewed the results from both neonatal 21 and older switches with very detailed information and 22 data on individual cases. 23 Can you recollect, Professor, was that data in the 24 form of a review of case notes or was it in the form of 25 oral information presented to you by the surgeons? 0023 1 A. I do not recollect. I think we had details certainly 2 for the 13 switches. Whether we had detailed 3 information for the whole series, I forget, but we had 4 details for the 13 switches and I think the surgeon went 5 through each of them at the time. 6 Q. When you say you had "details" of them, what details did 7 you have? 8 A. They were the diagnosis, the age of the patient, the 9 coronary anatomy and the outcomes. 10 Q. And you discussed that with the surgeons without 11 carrying out any independent review yourself of the case 12 notes? 13 A. That is correct, yes. We did not go through any case 14 notes. 15 Q. We see later, if we turn over the page -- I am sorry, 16 there is no note there of the fact that you were joined, 17 I think, at some point in this discussion by Dr Martin 18 and Dr Hayes. Can you remember that? 19 A. Yes, we saw them after having seen the surgeons. 20 Q. Did you have a discussion with them about the 21 environment for children at the Children's Hospital as 22 opposed to that at the Bristol Royal Infirmary? 23 A. That was discussed on the day, the particular time of 24 day I forget, but it was discussed. 25 Q. Can you recollect what input or additions the 0024 1 cardiologists gave to you in their meeting with you? 2 A. I think that we received a description of the staffing 3 of the cardiac surgery department. I forget the details 4 of that document, but I think we had a document from 5 them summarising their activities and their working 6 patterns and timetables. 7 Q. Was there any discussion, then, of the question of the 8 adequacy of the diagnosis that had been presented to the 9 surgeons in any of these -- 10 A. I think they acknowledged the fact that those patients 11 had not been diagnosed properly and there were some 12 deficiencies or weakness there, yes. 13 Q. Were you able to evaluate the quality of those 14 deficiencies, whether those were to be expected, given 15 the difficulties of diagnosing anatomy, or whether they 16 represented mistakes that were perhaps more surprising? 17 A. What I recollect, for example, is that coarctation -- it 18 does happen, you can always miss something like 19 a coarctation, but to miss a coarctation has major 20 implications for the operation. 21 To misdiagnose the type of coronary arteries you 22 are dealing with may have some effect on the mental 23 readiness of the surgeon, but the surgeon should be able 24 to correct that during the operation. Although, still 25 now, some surgeons in the UK would not undertake an 0025 1 intramural coronary artery repair, so they would be very 2 demanding on the accuracy of the diagnosis. If you have 3 an intramural coronary artery at the beginning of your 4 switch experience, it is a very, very difficult 5 situation because the risks are high, still high now. 6 If I remember it correctly, I think there were two 7 intramurals in that series of 13, which is very, very 8 bad luck, but I do not think we can incriminate the 9 cardiologists for not having diagnosed that in 1991, 10 because I think that the accuracy of the echocardiograph 11 diagnosis of the coronary arteries has improved a lot in 12 the last few years. I would not consider that it is 13 poor cardiology to have missed that pre-operatively. 14 To miss a coarctation is more important. 15 Q. I am not seeking, I hope, to incriminate anyone, but 16 certainly to explore and from that point of view, you 17 have mentioned obviously in your report the fact that 18 the failures with the switch programme were likely to 19 have been complex and dependent in large measure on the 20 performance of the team rather than an individual 21 surgeon. 22 Were you able, do you think, on your visit to the 23 BRI to get to the bottom of the contribution of the 24 cardiologists to the success or otherwise of the switch 25 programme? 0026 1 A. I think that it is certainly multi-factorial, and I am 2 convinced that the differences between success and 3 failure is in the small details in my recent study on 4 human factors, to which I alluded when I was here some 5 weeks ago, which confirms that what I have called "minor 6 negative events" have a major impact on outcomes. 7 I think that in any complex systems the variables 8 you are dealing with are more or less important, and 9 I think that those who work in the world of complexity 10 would recognise that in any complex system, there are 11 the so-called critical variables which are the most 12 important ones, and I believe that in terms of the 13 arterial switch operation, the surgeon is certainly one 14 of the critical variables, if not the most important 15 one, but a satisfactory pre-operative management is 16 important. An inter-operative team dealing with those 17 patients regularly is also vital. We did not have the 18 opportunity to go into the performance of the 19 Anaesthetic Department during our visit, but this is 20 very important. I think that patients with 21 transpositions are very vulnerable to any major changes 22 like aggression during the insertion of the catheters is 23 very important, so I think that the induction of 24 anaesthesia, the large insertion is very important. 25 Then there is the operation where, again, I think 0027 1 that the perfusionists are very important. We did not 2 go into this but the fact that those perfusionists were 3 dealing most of the time with adults might be of some 4 concern if they were not very familiar with children, 5 but again, we had not investigated this at all. 6 Then the post-operative management is absolutely 7 vital for those patients. Many of them are quite sick 8 afterwards and their survival depends on the very high 9 quality of the post-operative care which again is a team 10 effort which quite clearly did not exist there. 11 Q. Returning then to the process of your investigation, you 12 have listed a number of factors which you did not have 13 an opportunity or time to investigate fully and you have 14 mentioned, for instance, the anaesthetic contribution to 15 success. 16 How confident are you, or how happy are you, with 17 the method of investigation that you were obliged to 18 adopt as a means of reaching a conclusion upon the 19 adequacy of care at the unit? 20 A. I think that the report was carefully written. I think 21 that the report indicated its weaknesses and the report 22 mentioned the fact that the investigation should go well 23 beyond the surgeons but through the systems. I think 24 that was in the initial report. So I do not think that 25 the report was misleading or that the report did not 0028 1 achieve what it had to do; I believe that the report 2 provided some information which could have been useful 3 for the Chief Executive to investigate further, to try 4 to have a better understanding what was happening and 5 what had to be done. 6 Q. But there is a difference between producing the best 7 report that you can, given the material available, and 8 addressing that which I hope my question was seeking to 9 explore: the limitations of the material with which you 10 had to work? 11 A. I think the material was insufficient. Again, the 12 report was written four years ago, and I think that in 13 four years, understanding of performance in health care 14 has changed a lot as well. I think I certainly would be 15 even more demanding now than I was five years ago to 16 make comments or statements. 17 Q. More demanding by seeking to explore further the 18 contribution of other members of the team? 19 A. That is correct, or to state that no conclusion could be 20 drawn, for example, with the information that I had. 21 Q. Next on the note from Dr Hunter is the record of the 22 meeting with Dr Bolsin, if we can scroll up a little, 23 please. There is a reference there, is there, to the 24 calendar of events that he provided to you. He gave 25 you, did he not, a list or an account of events 0029 1 described as a "calendar of events". 2 A. Yes, he did. 3 Q. It may be, again, that Dr Bolsin will give evidence to 4 the Inquiry that he felt the manner in which he had been 5 questioned by yourself and Dr Hunter was a hostile one. 6 Do you have any comment to make on that 7 suggestion? 8 A. I think it is difficult to -- it is easy to say no, but 9 I do not recollect. What I recollect is that during the 10 meeting there was a sense of conflict which was present 11 there and I think the way Dr Bolsin presented his data 12 or the calendar of events was conflictual. Obviously it 13 is difficult to blame someone, to adopt that attitude 14 knowing what he had done for several years to try to 15 solve the problem. Whether our reaction has been 16 hostile or not, I cannot comment on this. 17 Q. You say that his manner was "conflictual". 18 A. Yes. 19 Q. Can you help us a little by expanding on that? 20 A. Obviously he felt there was a problem somewhere, and to 21 start to audit the performance of another discipline -- 22 which was, I think, done without the knowledge, 23 certainly not the co-operation or even the knowledge of 24 the surgeon -- is conflictual, in my view. I think that 25 the attitude to adopt in circumstances where there is 0030 1 a concern about performance is to make sure that the 2 performers are aware of it, and then are asked to 3 contribute to an assessment of an audit which would then 4 take place. 5 If our attitude was hostile, I suspect that it 6 might be related to that feeling we had when we saw what 7 had happened before. I am not sure. 8 Q. Two things. Firstly, you have described the way in 9 which Dr Bolsin had acted throughout the audit as being 10 "conflictual", but earlier, you were commenting on his 11 manner during the interview when you used the word 12 "conflictual". Can you help us a little further on his 13 manner to you at interview? 14 A. The feeling one had is that he had adopted, himself, 15 a hostile attitude towards the surgeon, because -- 16 Q. Is that "surgeon" or "surgeons"? 17 A. "Surgeons". Well, I think "surgeons", yes -- and that 18 this transpired while he was explaining what he had 19 done. But again, I do not recollect if that has been 20 the cause for us being hostile, or me or Dr Hunter. 21 I do not recollect. 22 Q. Dr Bolsin gave the results of his audit or discussed 23 them with a number of figures within the UBHT, including 24 at least figures within the anaesthetic department such 25 as the Clinical Director of anaesthesia, Dr Monk. 0031 1 When you comment on the manner in which this audit 2 was conducted and its secrecy, is it fair to suggest, in 3 effect, that the responsibility for bringing this audit 4 to the attention of the surgeons and seeking a joint 5 solution lay upon Dr Bolsin rather than, say, other 6 members of his department? 7 A. I think that the surgical department should have been 8 informed of this. I do not think it did happen until 9 some time later. Whether the Director of Anaesthesia 10 should have been more active or done something, it is 11 hard to tell. I would like to say that the data should 12 have done it, but if I try to take a situation which is 13 current, for example, and try to see what would happen 14 today, let us say, at Great Ormond Street, if a young 15 anaesthetist who -- I think that Dr Bolsin had been 16 appointed in 1989; is that right? 17 Q. In 1988. 18 A. So a junior anaesthetist coming to Great Ormond Street 19 today who, for example, spent a year with Dr Bovey, who 20 has the best results, or one of the best results, with 21 a particular heart syndrome, and assuming that a young 22 anaesthetist spent a year there, comes to Great Ormond 23 Street and the mortality is twice as high, it is 100 per 24 cent higher, let us suppose, and that anaesthetist, 25 without telling us, starts taking notes about our 0032 1 performance and goes to see the chief of anaesthesia to 2 tell him or her that the results are appalling, I am not 3 sure that more reaction would take place, because we 4 know the results; we are aware of the fact that our 5 results are not as good, and I do not think that more 6 action would take place today. 7 So retrospectively, I am not sure that I expected 8 more reaction, I must say. 9 Q. So that depends, does it, on the surgical department 10 already being aware of its results and being confident 11 in its mind of having the proper explanations for any 12 differences in outcomes that may be present between it 13 and another unit? 14 A. Yes, but though we are here in 1989 talking about the 15 arterial switch operation, for example, which started 16 about that year, and there was nothing to compare with, 17 or very little to compare with at the time in the UK. 18 We did not know what the results of the other units 19 were. We still do not today. Obviously the surgeons 20 were aware of those poor results. The question is 21 whether it is acceptable or not. I must say, I have 22 great difficulties in answering the question. 23 Q. Going back, though, to the method of conducting the 24 audit, if the junior anaesthetist that we are dealing 25 with in your unit has raised it with the Clinical 0033 1 Director of Anaesthesia, has at least notified him or 2 her that the audit is taking place, and perhaps a number 3 of other figures around the hospital, does that not 4 exonerate him, as it were, from the responsibility of 5 bringing it to the attention of the surgeons? 6 A. I must say, I cannot answer the question. There is 7 a lack of openness somewhere along the line. I think 8 the surgeon should have been informed, whether by the 9 Director of Anaesthesia or by the person who carried out 10 the audit, but if there is a feeling of sub-optimal 11 performance, whatever the cause of it is, it should come 12 into the open and be discussed. 13 Q. In any event, a lack of openness was something that you 14 took away, I think it is fair to say, very strongly from 15 your visit to the UBHT that day? 16 A. Yes. 17 Q. If Dr Bolsin recollects giving you a summary of outcome 18 data from an annual report dealing with the years of 19 1990 to 1991, do you have any recollection of that data 20 being given to you? 21 A. No, I do not. I have already said that and I do not 22 have it in my files, so either I forgot about it and 23 I did not take the document with me -- I think if that 24 document had been available, one of the two reports 25 would have mentioned that. You can ask Dr Hunter later, 0034 1 but I do not recollect that at all. 2 Q. So if Dr Bolsin recollects being questioned, he may say 3 in a hostile fashion, about that data, would your answer 4 be the same: that you have no recollection? 5 A. If I have not seen the data, it is difficult to comment 6 on those. I said that the hostile comment was about the 7 way he interviewed, not specifically about this data in 8 1991 which I have not seen, I suppose. 9 MISS GREY: Sir, I am conscious of the time. I wonder 10 whether this might be an appropriate moment to break for 11 10 minutes or a quarter of an hour? 12 THE CHAIRMAN: Yes. Shall we take 15 minutes, then, and 13 reconvene at about 10 past 12? 14 (11.50 am) 15 (A short break) 16 (12.10 pm) 17 MISS GREY: Professor, we were looking at this minute 18 provided by Dr Hunter before the break. If we could 19 just scroll down the page a little, please, we will see 20 that the last sentence on that line is Dr Bolsin's 21 observation that the anaesthetist did not take part in 22 the decision-making process at referral meetings, and 23 therefore were presented with difficult problems 24 post-operatively. 25 First of all, can you recollect that comment being 0035 1 made by Dr Bolsin? 2 A. I do not, but it does not mean he did not make it. I do 3 not recollect it. 4 Q. Out of your more general experience, can I ask you, 5 first of all, would it be normal, in your experience, 6 for anaesthetists to be present at referral meetings? 7 A. It is not, but I think it is an important point. It is 8 a point I have addressed to myself at Great Ormond 9 Street on several occasions. 10 I believe that if you have a critical mass of 11 patients which can justify to have two or three 12 anaesthetists mainly involved in paediatric cardiac 13 surgery, those anaesthetists could be involved in the 14 overall management of the patients, but by and large it 15 is not the case in any institution in this country, and 16 very few in the world, I believe, and most anaesthetists 17 have lists in a number of specialties and cannot take 18 part in discussions, but I believe it will be a step 19 forward in the management of those patients if one could 20 achieve that, but it is not the case. 21 Q. What could the consultant anaesthetists add to those 22 management meetings and take from them for future care? 23 A. What happens, and I suspect it happened in Bristol as 24 well, is that we review once a week the operations that 25 we are going to do the following week with the 0036 1 cardiologists, the surgeons, and a number of patients 2 may have different anaesthetic risks of which the 3 anaesthetist could not be aware of. I think it is 4 important, again, in terms of mental readiness to have 5 the maximum of knowledge of the problems that you are 6 going to tackle, and I think it is important to have the 7 time to think about it, other than to face the problem 8 as it is presented to you. 9 What does happen is that the anaesthetists do see 10 the patients, usually the night before the operation, 11 but I think if they could be part of a multidisciplinary 12 decision-making process, that would be good for the 13 patients. 14 Q. So you understand what Dr Bolsin is saying if he is 15 saying, as is recorded in the minute, that the 16 anaesthetist could be presented with difficult problems 17 post-operatively, if there was not that pre-operative 18 involvement? 19 A. Yes, but in my experience, the obstacle is from the 20 anaesthetists. There are those who do not want to do 21 it. They say they cannot do it because their working 22 pattern is different, and because by and large they 23 refuse to spend their lives doing paediatric 24 anaesthesia, because it is, according to them, more 25 stressful than what they do and they do not want to do 0037 1 that only. 2 Q. You mention, if it would be worthwhile reorganising to 3 allow this sort of joint meeting to take place, if there 4 were a "critical mass" of patients. 5 What sort of numbers would be needed to 6 generate -- 7 A. You must have also the agreement of the anaesthetists as 8 a profession to accept, to become so specialised that 9 they would do mainly paediatric cardiac surgery and that 10 has not been agreed at all. But I would suggest -- 11 I have already mentioned that here -- that a centre 12 doing 400 or 500 cases a year could justify having an 13 anaesthetist who would be involved in the overall 14 management of those patients, which is not only the 15 operating theatre but also the cardiac catheterisation 16 laboratory and also perhaps take part in the 17 post-operative management. I personally believe that it 18 is important for each member of those teams to have 19 areas overlapping to facilitate interfaces, but again, 20 there is a very serious obstruction from the 21 anaesthetists with this. 22 Q. 400 or 500 paediatric cases? 23 A. That is correct, yes. 24 Q. Before leaving the meeting with Dr Bolsin, can I ask 25 you: was there any direct discussion with Dr Bolsin of 0038 1 the circulation of his audit data? 2 A. I do not recollect that. 3 Q. If we can move over the page, please, page 16, and 4 scroll down the page, please, to the discussion with 5 Sister Thomas, we see at the bottom there that she had 6 worked for eight years in cardiothoracic surgery. 7 If we turn over to page 17, there is there 8 a record of Fiona Thomas setting out her views that 9 there was still a considerable conflict between surgeons 10 and anaesthetists, and she did not appear to be greatly 11 enamoured at the way in which ITU was run for children. 12 Can I ask you first, what impression do you 13 recollect that Sister Thomas gave you as to potential or 14 considerable conflicts between surgeons and 15 anaesthetists? 16 A. Evidently the decision-making was highly disorganised. 17 I think that the surgeons and the junior surgical staff 18 would first come in the morning to see the patient, 19 write the orders; could be changed by the consultant 20 surgeons; the anaesthetist could come at different 21 times. There was a complete lack of cohesion in 22 organisation in the management of those patients. 23 Nobody knew who was in charge of the patients. It seems 24 that the surgeons had the last word, but as it happens, 25 very often the surgeons are not there necessarily when 0039 1 problems occur, so it was highly unsatisfactory. 2 Q. Was that information that you got from Sister Thomas, or 3 was that a more widespread view? 4 A. I forget now. In the report I had used the word "highly 5 disorganised" for the Intensive Care Unit. It was 6 mainly from her interview, I think. 7 Q. She is recorded as saying that she did not appear to be 8 greatly enamoured of the way ITU was run for children. 9 Did you pick up from her or from others 10 information about the way in which the paediatric care 11 was handled in ITU? 12 A. Again, we did not go to the Intensive Care Unit, but my 13 understanding is that those children were amongst the 14 adults and that the staff there were more familiar with 15 the treatment of adults than of children and that the 16 junior doctor on duty was also not a paediatric expert, 17 so more familiar with the adults. So I suspect what she 18 means here is that they did not appear to be greatly 19 enamoured to look after children. 20 Q. If we scroll down, please, we see the record of the 21 interview with Professor Angelini. Do you have anything 22 to add from your recollection of that meeting, to that 23 note? 24 A. No. I had a feeling after that meeting that there was, 25 again, probably a conflictual relationship between the 0040 1 Professor of Cardiac Surgery and the other two surgeons, 2 but I did not go into the details of this. I do not 3 know if it was a consequence of what had happened or if 4 it started like this when Professor Angelini was 5 appointed two and a half years before. 6 Q. Is that something that you can specifically recollect 7 arose out of your interviews at that time as opposed to, 8 say, your subsequent knowledge of events, in, for 9 instance -- 10 A. No, it was at that time, yes. 11 Q. Further down the page, we see that Dr Monk's 12 contribution is praised as being "lucid and logical". 13 Is that an impression you took away as well? 14 A. Yes. 15 Q. He is recorded as saying that the results from surgery 16 were "less than adequate". Can you explain what he said 17 to you? 18 A. I do not remember the details. I do not think he 19 produced any figures or at least no comparative 20 figures. It was just his clinical impression that the 21 results were not good. 22 Q. Was it related to specific procedures or was it 23 a generalised comment? 24 A. I am not sure. I think the switch was mentioned as 25 a procedure, but I cannot be more specific on this. 0041 1 Q. He then goes on to say there had been unsatisfactory 2 access to figures until quite recently. Did he say what 3 access to figures he had been given, firstly by the 4 surgeons? 5 A. I think he alluded to the difficulties of obtaining 6 figures from the surgeons until our visit took place. 7 This is what he meant. 8 Q. Did he discuss whether he had asked for figures from the 9 surgeons? 10 A. I do not recollect that. 11 Q. So what you remember is a generalised comment that it 12 had been difficult? 13 A. That is right, yes. 14 Q. But no more details? 15 A. No more details no. 16 Q. Or details in particular of whether or not he had 17 actually asked for information? 18 A. No. I do not recall what exactly he said at the time, 19 but I think that there were many general comments that 20 he made. 21 Q. What about access to figures by Dr Bolsin? Was there 22 any discussion of that? 23 A. I do not think so. I do not think he commented on those 24 figures, but I may not be right. 25 Q. As Clinical Director of Anaesthesia, he would 0042 1 presumably, one might have thought, have the standing or 2 authority to ask for figures from the surgeons concerned 3 if there had been perceived to be a need for them? 4 A. Possibly, but again, if I am trying to see what I would 5 do, for example, if my Senior Registrar was complaining 6 about an anaesthetist and was trying to audit the time 7 it takes for an anaesthetist to prepare a patient for 8 surgery, whether I would take action or not, I am not 9 sure. 10 Q. If you would not take action, why not? 11 A. I think that I would probably initiate an open 12 discussion to say that there is some concern, but 13 I probably would not at that stage go to the figures. 14 I just have a feeling that it is not the right attitude 15 to start an audit exercise without the people who are 16 investigated knowing about it. So I would use the 17 opportunity to express some wishes to initiate an audit, 18 ask them to do it, but I would certainly not use the 19 figures at the time. 20 Q. So you would bring it out into the open? 21 A. That is right, yes. 22 Q. And generate a discussion? 23 A. Yes, to try to have a constructive attitude, rather than 24 a conflict right from the start, yes. 25 Q. And presumably, as part of that constructive attitude, 0043 1 you would seek to achieve some form of consensus on how 2 the matter was then to be handled? 3 A. Yes. 4 Q. Whether one party or another would say, go forward with 5 the figures, or whether that was the way forward at all? 6 A. Yes. 7 Q. You are nodding. I think that was a yes, was it, for 8 the sake of the transcript? 9 A. Probably, yes. 10 Q. If it is a less than qualified yes, do say so. 11 A. It is "Yes". 12 Q. If we look back at your own witness statement and its 13 account of the meeting with Dr Monk -- this is 14 WIT 319/3, towards the bottom of the page, under the 15 heading "other hospital staff", the last part of that 16 paragraph mentions that he emphasised the poor results 17 of the switch operation, which in his opinion did not 18 only reflect on surgery but on the overall team 19 management. 20 Can you remember any of the elements in the 21 judgment that he was making there? 22 A. I do not, but my recollection is also that I had been 23 impressed by Dr Monk, precisely because his overview of 24 the problem, he was not considering his comments on the 25 surgeons only but on the overall management of the 0044 1 patient, which was I think the most positive discussion 2 we had during the day. 3 Q. But you cannot remember the threads -- 4 A. I do not remember the details. 5 Q. Looking up the page, the beginning of that paragraph, 6 N7, Dr Pryn was concerned about the lack of hard data? 7 A. Yes. 8 Q. Did he make any comments on access to data? 9 A. I do not recall. He probably made a similar comment 10 that they had difficulties to get the data from the 11 surgeons. 12 Q. I think it may be if we look back at the minute we have 13 just looked at, he was one of those who commented that 14 they had only had the results on the preceding night; 15 do you remember that? 16 A. I do remember that. That was acknowledged by the 17 surgeons as well. 18 Q. He went on to point out a disparity between the 19 expertise of the two surgeons. What was the contrast 20 that he was drawing there? 21 A. He was making the point that the results of the 22 performance of one of the surgeons was less satisfactory 23 than the other one. Whether he went into the details of 24 the switches or the AV canals, I forget, but he 25 indicated that there was a difference in the results, 0045 1 but without giving data. 2 Q. So you are unable to help us as to which surgeon he was 3 suggesting was more or less expert, or was he 4 criticising both in relation to different procedures? 5 A. No, he indicated the results of Mr Dhasmana were better 6 than the results of Mr Wisheart. 7 Q. Was that something that you eventually felt able to 8 corroborate in any way, or to disagree with? 9 A. Well, I think that I did agree with that and in the 10 tables we sent with the report we indicated that the two 11 surgeons had different results in terms of 12 atrioventricular septal defect, certainly, and leaving 13 aside the arterial switches, the results of Mr Dhasmana 14 were satisfactory, in our opinion. 15 Q. If we can go back to the report, please, UBHT 52/263, at 16 the bottom of that page it sets out your judgment and 17 that of Dr Hunter on post-operative management. You say 18 there that it appears to be highly disorganised with 19 conflicting decisions between the various parties 20 involved. 21 Is there anything further that you can assist the 22 Inquiry with, because we have covered this in some 23 measure already, as to the evidence upon which that 24 judgment was based? 25 A. No. It was mainly from Sister ... 0046 1 Q. Sister Thomas? 2 A. Yes, who discussed the post-operative care. I do not 3 think we had any other information than that. It says 4 as she explained, what evidence, with the number of 5 people coming to see the patients without any team 6 effort and with the intensivists who are not on site all 7 the time, and therefore provide a service which is 8 intermittent. 9 Q. Was that criticism not put to the surgeons or the 10 anaesthetists concerned? 11 A. Criticism? I do not think that the person who made 12 those comments was criticising surgeons or 13 anaesthetists, it was the fact that the post-operative 14 management was disorganised. 15 Q. It may have been a fact to her, but it might well be 16 that the surgeons concerned and the anaesthetists and 17 the surgical senior registrar and the SHO might have 18 disputed it. Did any of them have an opportunity -- 19 A. No, we did not discuss specifically the post-operative 20 management of either with either the surgeons, the 21 cardiologists or the anaesthetists. 22 Q. And it was not raised in the general discussion that 23 rounded off the day, then? 24 A. I do not think so. 25 Q. So why is it that you say that that judgment which you 0047 1 felt confident enough to include in the report you sent 2 to Dr Roylance, should not have been publicised without 3 further investigation? I am looking there at WIT 319/1, 4 please. This is your witness statement, at the bottom. 5 A. I think that the comment about the post-operative care 6 is based on information and data which are as weak or as 7 strong as the data set we had received throughout the 8 day. I think that if someone describes to me the way 9 the patients are looked after post-operatively, saying 10 that three or four different people come between 11 8 o'clock and 10 o'clock and overrule their own orders, 12 I think it would be very unlikely that the management of 13 those patients is appropriate. I would confirm that 14 today, as well. 15 Q. But that implies that the judgment in the first report 16 was accurate and fair -- 17 A. It was accurate. 18 Q. -- and could have been publicised without further 19 investigation? 20 A. Well, again, this could apply to the data. I think that 21 if someone tells that you a surgeon has done eight 22 atrioventricular septal defects with seven deaths, 23 I think I would again today say this surgeon is a high 24 risk surgeon, but I would not like this to be published. 25 Q. Because you would need to check the data? 0048 1 A. Absolutely, and not only that, make sure that they are 2 validated, to see the risk stratification, exactly what 3 the patients were, et cetera, yes. 4 Q. If we can go back to the report, please, 52/264, you set 5 out there the background of the current problem. Would 6 I be right in thinking that the history of events there 7 set out is taken primarily from Dr Bolsin's calendar of 8 events? 9 A. Yes. 10 Q. And just for the sake of the record, if we look, please, 11 at UBHT 61/49, please, is that the document that 12 Dr Bolsin gave to you? 13 A. Yes. 14 Q. If we can go back to the report, one of the events that 15 is set out there in the second paragraph, "Background of 16 current problem" is the fact that in 1993 one paediatric 17 cardiac surgeon went to the Children's Hospital in 18 Birmingham to improve his technique on the switch 19 operation. He went, I think as a matter of record, 20 twice and on the second occasion, he took an 21 anaesthetist, a perfusionist and two nurses along. 22 On both occasions, I think again it is accurate to say, 23 he watched operations being conducted by Mr Brawn. 24 Are you able to help the Inquiry as to the 25 appropriateness of that form of retraining, judged in 0049 1 the context of the standards of retraining or training 2 at that time? 3 A. He recognised the problem and he tried to solve it by 4 visiting someone who was achieving better results. 5 I have never found the definition of retraining. I have 6 used the word in my paper on the "Cluster of Failures", 7 and I still do not know what it means. Obviously 8 retraining may indicate training to understand or try to 9 pick up some technical details of a procedure or the 10 management of the perfusion, the bypass, so I think that 11 if you are facing failures, by definition you do not 12 know exactly where the figure arises from. I think as 13 surgeons we have a tendency, at least most of us, to 14 incriminate the skill or the actual technical 15 performance of the procedure, which I think is very 16 shortsighted. We all make the mistake. So I think when 17 you have a problem, you are in the dark and it is very 18 difficult to decide whether it is appropriate, not 19 knowing exactly what the cause of the failure was, and, 20 for example in my own experience, I decided to retrain 21 by doing the same, going to see Bill Brawn and having 22 him to help me to do one or two switches, and 23 I believed, when I started to do the switches myself, 24 that I had learned some technical tricks. 25 Five years later, I had realised that the way I do 0050 1 the switches is the way I did them before my "Cluster of 2 Failures", not the way I learned it, and I am convinced 3 that my retraining has given me back the confidence that 4 I had lost and I think this is the most important point, 5 to reach a state of mental readiness which is such that 6 you cannot proceed with confidence and you have to 7 regain it. 8 Whether this is what Mr Dhasmana was looking for, 9 I am not sure. I think that the word "retraining" here 10 might not be appropriate because he had never achieved 11 good results in the switches, so it was a question of 12 training rather than retraining, which is slightly 13 different, I believe. So it was the problem of 14 initiating a new form of treatment, a strategy, the 15 arterial switch operation having failed, while you start 16 to implement that new strategy. 17 Q. I think it is fair to record that the word "retraining" 18 came from me and was no doubt inaccurate. The word you 19 use in the report is "improvement": he went to 20 Birmingham to improve his technique. Is that a better 21 characterisation of what you understood to have been 22 taking place? 23 A. I think so. 24 Q. But the difference between the form of study that you 25 undertook and that Mr Dhasmana undertook in 1993 was 0051 1 that when he went to Birmingham, he watched operations, 2 whereas I think you were assisted by Mr Brawn in 3 carrying them out. Is that a material difference? 4 A. I did both. If I am correct, I believe that Mr Dhasmana 5 tried to have the same type of help as well, and that 6 Mr Brawn did not find it possible for him to either go 7 to Bristol or he did not have the time to do it -- 8 I have forgotten the details -- but I think that 9 Mr Dhasmana was hoping to have that type of support. 10 Q. We may hear that whatever he tried to achieve, he was in 11 effect offered a choice between attending at Birmingham 12 to see Mr Brawn in action and having Mr Sethia come to 13 Bristol to assist in Bristol. 14 If that was the choice presented by Mr Dhasmana, 15 and clearly it is something that he either will or will 16 not confirm to the Inquiry directly, do you have any 17 critical comment on the choice that he did make to go to 18 Birmingham? 19 A. I think it is a very difficult question, on the one hand 20 from the person who is receiving help and on the other 21 hand from the person who is offering to help. I have 22 helped lots of people or surgeons to do some operations, 23 but it is a huge responsibility you are taking up to 24 accept to help someone to perform a new operation and in 25 a way, to have some responsibility in the outcomes, and 0052 1 I sometimes do not accept it because I do not feel that 2 I like to take that responsibility. 3 The choice between having Mr Sethia in Bristol or 4 visiting Mr Brawn, I think it is a question of personal 5 relationships which also, I think, is very important. 6 It is, I think, not that easy for a senior surgeon to 7 find another surgeon with whom you relate well, to learn 8 something new or to solve a problem, and I think 9 surgeons are not the easiest people to deal with, and we 10 all have our weaknesses in personalities, and it is 11 sometimes very difficult for two surgeons to work 12 together. 13 Q. You talk about personal relations. Is there anything 14 about the school of surgery in which Mr Brawn and 15 Mr Dhasmana were trained that might make it more natural 16 for Mr Dhasmana to prefer to go and see Mr Brawn? 17 A. I think so. I have never seen the individual results of 18 Mr Brawn or Mr Sethia, but I believe that one of the 19 most important schools of paediatric cardiac surgery has 20 been the school of Castaneda in Boston, which has 21 produced, I think, excellence which seems to be 22 transmitted from one generation to the other. Mr Brawn 23 was trained by Roger Mee, who was one of the first 24 pupils of Aldo Castaneda. 25 So I believe that in 1995, 1993, if I were, 0053 1 myself, to choose between the two surgeons, I probably 2 would have taken someone coming from that school. 3 Q. The next event recorded in that account of events after 4 the approval of Professor Angelini is a joint meeting 5 between the cardiac surgeons and the paediatric 6 cardiologists and the cardiac anaesthetists, in which 7 the surgeons reassured their colleagues that the results 8 were improving. 9 Firstly, were you given the impression that 10 results were presented to this joint meeting? 11 A. No, I do not think that any hard data had been produced 12 for that meeting. This is my recollection. 13 Q. If the surgeons reassured their colleagues that the 14 results were improving, is that a statement that you 15 would have expected to have been based on hard data? 16 A. Well, I would have been reluctant to accept the 17 statement without any hard data. 18 Q. Were you yourself able to make any judgment on the basis 19 of the data that you were presented with as to whether 20 the results were improving by that time? 21 A. I think that we had two periods in the results produced 22 on that day and I think the second period went better 23 than the first, but I have to go back to my ... I mean, 24 this is in the tables we added to the first report. 25 Q. We can look at page 269. 0054 1 A. No, that is only a single period, so we have no evidence 2 of a trend here. But the meeting we are talking about 3 took place in 1993, so presumably the surgeons were 4 commenting on results obviously before 1993, which more 5 or less precedes this era. 6 Q. The data you were presented with by the surgeons? 7 A. Yes. 8 Q. Speaking of the data that was presented to you by the 9 surgeons, you gave evidence I think earlier to the 10 Inquiry that you did not yourself ask for any data prior 11 to your visit to Bristol? 12 A. That is correct. 13 Q. Is that correct? 14 A. Yes. 15 Q. If Professor Angelini received the impression from 16 whatever source -- he will have to help us on that 17 source -- that you had asked whether before your visit 18 or at some other time, for some ten years of data on 19 operations by the cardiac surgeons, do you have any 20 recollection of such a request? 21 A. Not at all, and I suspect that I would have put it in 22 writing, I think, if I had asked for that. 23 Q. Just to clarify, when you say you did not ask for data 24 in advance, you were then presented with data, is it 25 also right to assume that you did not ask for any 0055 1 further data at the end of your visit? 2 A. No. 3 Q. If we turn back to page 264 -- 4 A. Incidentally, Dr Angelini had written -- shortly before 5 the meeting -- a very short note to say that he was 6 hoping that we would help them and indicated the task 7 may not be easy but makes no comment about the data. 8 Q. I think we can probably turn that up. 9 THE CHAIRMAN: Can we see that, Miss Grey? . 10 MISS GREY: If we look -- 11 THE CHAIRMAN: Shall we do it at the break and move on? We 12 can come back to it. I am anxious that we do not refer 13 to any material which is not available to everybody. 14 THE WITNESS: I am afraid I do not have it here. 15 MISS GREY: We can find that. I should have the reference 16 at my fingertips, but I do not. 17 If we go back, then, to the discussions on this 18 page, we see that there is a reference there to a letter 19 or a discussion between Professor Angelini and Professor 20 Farndon on 24th July 1994. Were you ever given any 21 document that might have underlined that event? 22 A. I do not think so. 23 Q. At the bottom of the page there is a reference to the 24 non-infant switch and the discussion of that. 25 As the record reads there, it says that an 0056 1 agreement was reached to proceed with the operation. It 2 suggests that all parties concerned at the meeting 3 agreed with that decision. 4 Is that an accurate summary of events? 5 A. Actually during the coffee break I tried to answer the 6 question about hostility. I remember that the only 7 comment I made which could have been taken as being 8 hostile was precisely about this particular patient 9 where we were told there was a unanimous decision to 10 proceed, and Dr Bolsin did not agree with that; he 11 disagreed with that statement. Then I think I am 12 correct in saying he agreed that he had accepted to 13 proceed on medical grounds, but not politically, 14 "political" is the word he used, but there was 15 a medical agreement. I suspect I may have shown some 16 signs of irritation that that distinction was made. 17 I think this is the only recollection I have of being 18 perhaps seen as being hostile. 19 Q. You yourself did not understand or did not sympathise 20 with the distinction that was being made? 21 A. No, I think that the purpose of the meeting was 22 a medical decision and a full agreement had been reached 23 to proceed on medical grounds. I did not see why 24 a political reason could have been influential in the 25 decision-making. Obviously, with hindsight, we could 0057 1 argue that the patient should not have been operated on 2 I am not sure, having seen the details, but if the 3 purpose of that meeting was to decide on medical 4 grounds, they had reached agreement on this, I believe. 5 Q. If we go on, please, to page 265, you set out then the 6 forward steps that you understood had been already 7 agreed upon, is that correct, within the Trust? 8 A. Yes. 9 Q. Going down the page, perhaps I could just fill in the 10 reference now before we go on any further, thanks to the 11 assistance of Mr Maclean: UBHT 61/338, please. 12 (Pause). 13 A. That is correct. There is no indication of having 14 discussed data with me. 15 Q. If we turn back to the report at 265, please, under the 16 heading of "Perceptions ...", you speak there of the 17 auditing activities of the surgical results by the 18 anaesthetic department. 19 Was it accurate to speak of the "Anaesthetic 20 Department" on your understanding of events? 21 A. I believe that we had been told in a meeting that it was 22 Dr Bolsin with the assistance I think of Dr Black -- is 23 it possible? 24 Q. Yes. 25 A. -- so this is why I used "Department" rather than 0058 1 "individual". 2 Q. Why did you reach the conclusion that that lacked 3 a collaborative attitude? 4 A. Because as I said before, such an activity, to me, 5 should have been done with at least the knowledge of the 6 surgeons, which was not the case. So I think that 7 should be done in the open, from the start. 8 Q. You then go on, at paragraph 2, to talk about the 9 surgeons' reticence to produce and analyse their own 10 results. 11 What was the judgment that the surgeons had been 12 reticent in production of results based upon? 13 A. It was quite clear from Dr Bolsin's interview and from 14 the head of anaesthesiology, that they had great 15 difficulties to obtain the results. It was, I think, 16 clear also that when they met in 1993, the surgeons made 17 a statement which was not supported by data and that the 18 number of the people we had seen on that particular day 19 in February had been presented the surgical results for 20 the first time, so there was an obvious reticence from 21 the surgeons, because even the first time they were 22 informed of the audit in 1993, during the meeting they 23 had, it was two years before, so I think that there was 24 a reticence. 25 Q. This question depends on my correct identification of 0059 1 the meeting in 1993, but it may well be that the Inquiry 2 will hear that at that meeting Mr Wisheart put figures 3 up on a blackboard and so, therefore, did present the 4 results of the unit in the form of a sketch, data, on 5 a blackboard. 6 Does that alter your answer in any way? 7 A. Again, I must say that if that scenario happened at 8 Great Ormond Street at that particular time, even if we 9 had done our very best to get the data, we would have 10 found it very difficult to get accurate data. So it may 11 be more than reticence to produce the data, it may be 12 that it was not practically possible to do it. 13 Q. What were the norms for data collection in your own unit 14 during this period? Let us look first at the period 15 from 1990 to 1993. 16 A. It is highly unsatisfactory. What we had at Great 17 Ormond Street, and still have, what we call a monthly 18 death conference or mortality and morbidity conference, 19 where the activity of the month is summarised in terms 20 of name, age, diagnosis, outcomes, complications are not 21 listed per patient, but sometimes summarised at the end 22 of the report. Then there is a detailed summary of the 23 patients who died. 24 Those death conferences are printed and from them 25 we extract the data which is sent to the UK register for 0060 1 the death conferences, but we do not have a database 2 where all the patients are entered. 3 Q. But was there ever any attempt to present not merely the 4 month's figures but, say, an annual review -- 5 A. No. 6 Q. -- or a review of series? 7 A. No. 8 Q. I asked you about the period from 1990 to 1993. 9 By the time you came to Bristol in January 1995, 10 had that position as you describe it changed in any way? 11 A. At Great Ormond Street? No. 12 Q. What about the process of making an annual report for 13 either audit purposes or possibly at a time when the 14 service was still designated as a supra-regional service 15 to the Department of Health? Was there no data 16 collection process for that purpose? 17 A. All the data we have ever sent from Great Ormond Street 18 were from those death conferences. 19 Q. Going on, then, to paragraph 3, you describe there the 20 process of channeling concerns upwards to the Department 21 of Health before professional bodies as being 22 "unfortunate". 23 Can you tell us what your expectation as to the 24 norms for tackling these sorts of concerns was at the 25 time when you made the report? 0061 1 A. I would have hoped that the College of Surgeons, for 2 example, could have been approached or the -- I am not 3 sure if the British Paediatric Association was in 4 existence in those days. I do not think they were; it 5 was just the beginning. But the Society of Cardiac 6 Surgery or Cardiology could have been approached as 7 well, I think. 8 Q. Why would that have been more acceptable or suitable 9 than going to the Department of Health? 10 A. I think that if a problem arises, I think first of all 11 the people implicated should be fully aware of it and 12 should contribute, do their best to understand and solve 13 the problem. So the first step is in the institution of 14 the department the problem arises from. And I believe 15 that the profession should play a role in helping solve 16 those problems before they call the Department of 17 Health. Obviously, if the professional bodies are not 18 of any help, one has to go further. 19 Q. What legitimate interest or responsibility do you think 20 that the Department of Health had in this matter? 21 A. I think the Department of Health is ultimately 22 responsible for health care and care provision in this 23 country, so I think they should play a role there. 24 Again, looking at the overall problem, I think that the 25 fact that the cardiac surgery took place on two sites, 0062 1 for example, is a problem which goes well beyond the 2 Department of Cardiac Surgery in Bristol, even in the 3 Trust, I think. 4 Q. Because it relates in part at least to funding issues? 5 A. Yes, precisely. 6 Q. But the Department, after these events had taken place, 7 when the feeling was expressed to them that they were 8 outsiders who should not have been approached until 9 a later stage, replied that they saw themselves as being 10 part and parcel of the family of health care providers. 11 Why should they be the last port of call; health care 12 professionals, other professionals, approached first? 13 A. This is my view -- I do not think it is based on any 14 form of legislation. I think that if we believe that 15 professional self-regulation should play an important 16 role in enhancing or improving health care or reaching 17 excellence, that would be the way to proceed, to go to 18 the profession first. 19 Q. So paragraph 3 is ultimately based upon an 20 understanding, in your view, of the importance of 21 professional self-regulation? 22 A. Yes. 23 Q. Moving on to paragraph 4, then, you say at the bottom of 24 that paragraph, the end of the paragraph, that there was 25 no hard data on morbidity. 0063 1 Again, drawing on your experience of data 2 collection at the time, would you have expected there to 3 be such hard data? 4 A. No. We have at Great Ormond Street some hard data on 5 morbidity in the Intensive Care Unit only in the last 18 6 months for the first time. 7 Q. What was it that made data collection on morbidity 8 relatively slow to start up and be collected? 9 A. I think we already are behind that collection in terms 10 of mortality. Morbidity is the next step. 11 Q. When you say "we are already behind", whom do you mean 12 by "we"? 13 A. I think at least we at Great Ormond Street, but it 14 applies to many other centres as well, I think, yes. 15 Q. A related subject: there was no hard data on morbidity. 16 Can I ask you, Professor, what your experience was of 17 discussing the subject of morbidity with parents at the 18 time of the terms of the Inquiry? If you go back to, 19 say, 1990? 20 A. In my own practice, I usually did not specify potential 21 problems, other than chances of success or failure, so 22 I would quote a risk of success which means survival 23 without major or irreversible morbidity. This is what 24 I mean. But I was never explicit in terms of going into 25 the details of morbidity. For example, we, until recent 0064 1 years, never specified that there was a risk of brain 2 damage after heart surgery. 3 Q. But you have said that you define "success" to yourself 4 as meaning not the difference between life or death, but 5 the difference between life without major neurological 6 complication, or death. 7 Can you explain to us whether or not the meaning 8 of "success" would have been explained to parents in 9 those terms? 10 A. It was not, no. It was just a global risk without being 11 specific whether it was morbidity or mortality. 12 Q. So was there any explicit discussion with them at that 13 time of the risks of brain damage? 14 A. No. Obviously some parents would question the 15 complications and we would obviously answer the 16 question, but we would not spontaneously bring out the 17 topic of brain damage. 18 I think there is a problem of culture and also of 19 readiness of patients to accept this. At Great Ormond 20 Street we often have at least one or two Senior 21 Registrars who have completed their training in 22 America. In many States the list of risks (not only of 23 brain damage) has to be read to the family or to the 24 patients. It was quite common, on the first week of 25 July each year, when those residents came to work with 0065 1 us, to see parents in tears, totally distressed, because 2 it was precisely indicated that their child could have 3 brain damage the following day. 4 So I think there is a problem of culture which has 5 changed quite a lot in the last few years, and obviously 6 now, even if we distress the parents, we would mention 7 that, but it was not specifically mentioned at the time. 8 Q. When did your practice change, roughly? 9 A. I think it has changed. I became involved in court 10 cases where patients had suffered brain damage and the 11 first question that the legal expert would always ask 12 is: "Did you tell the family? If you did, it is fine. 13 If you did not, it is not fine at all". So this is when 14 I started to do it, but I must say, with reluctance, 15 because of the impact on the families. I have a feeling 16 that very often the families actually are aware of this 17 because they have discussed open-heart surgery, but to 18 spell it out seems to be very traumatic. 19 Q. You told us of events, the pressure of litigation. Can 20 you date that in chronological terms at all, within the 21 last -- 22 A. I think that nowadays I have always a witness with me. 23 I mention the neurological risks and I write it down, 24 and this is for the last two years -- the last two or 25 three years. 0066 1 Q. You have talked of a change in medical culture: doctors 2 now changing their practice. What about the 3 acceptability of that information for parents? Has 4 their reaction to this sort of data changed in any way? 5 A. I think so. I think in the past the majority of the 6 patients had established a relationship of trust and 7 they were aware of risks without being willing for those 8 to be specified, knowing that everything possible was 9 done for their child and I think that attitude has 10 changed. Patients and parents are more demanding. They 11 want to know more precisely what the potential risks 12 are, which is obviously correct, and the doctors not 13 only are more open about the risks of failure, but also 14 are more aware of their own risks of litigation. So it 15 is a combination of a number of issues which has changed 16 the practice. 17 Q. I have taken you away from the report to discuss that 18 issue. If we go back, please, to paragraph 5, you talk 19 about the tension that has arisen from this long saga 20 creating an atmosphere of distrust and lack of 21 confidence and then you add that that has made the 22 working conditions for the surgeons "nearly untenable." 23 What was that perception based upon? 24 A. It is based upon personal feeling that if I had been 25 asked to operate a high risk patient in Bristol in 0067 1 February 1995, I would have refused. I would have been 2 unable to do it because I felt that it was not a team 3 effort, that I was watched for the worst and that the 4 pressure would have been such that my performance would 5 have suffered from it. So it is a personal statement. 6 Q. If we look at the statement of Dr Hunter on this matter, 7 he comments at WIT 322, please, page 6, under the 8 heading "Conclusion" that "The visitors sensed a lack of 9 communication between the various parties involved and 10 felt that this was at the root of the problem facing the 11 Trust." 12 Firstly, would you agree with that as an 13 observation? 14 A. Yes. 15 Q. If you go on, he then goes on to say: 16 "Those who initiated the audit activities gave the 17 impression that they were intent on policing the 18 surgical activities rather than working together to see 19 a solution." 20 Again, is that a comment that you would agree 21 with? 22 A. Yes. 23 Q. What would you understand the word "policing" to mean in 24 that context? 25 A. I think that it was not a cost-effective way to improve 0068 1 a situation. It was an activity to demonstrate failure, 2 which I think it is important. But not done in 3 a constructive way, basically. So it is a good 4 intention, but poorly conducted. 5 Q. The last sentence of that paragraph: 6 "There was in general a lack of understanding of 7 the problems of paediatric cardiac surgery." 8 A. I am sure you can ask Dr Hunter what exactly he meant by 9 this sentence later. The way I understand it is that 10 they were not, in a specialised environment, at all 11 levels where there was enough knowledge to deal with the 12 children on the same site. 13 Q. What about the working conditions of the anaesthetists 14 in this setup, and in particular, that of Dr Bolsin? 15 Did you consider the attitude or regard in which he was 16 held by the other members of his department? 17 A. No. I do not have a feeling for this. I cannot answer 18 your question. 19 Q. Because it might be said on Dr Bolsin's behalf that it 20 was he who felt that he had to leave the unit ultimately 21 because of the way in which he was treated? 22 A. Well, I have no knowledge of the reasons for his leaving 23 and the possible problems within the department. I am 24 not aware of it. 25 Q. It was not an issue at any rate that you picked up at 0069 1 the time you visited? 2 A. Not at all, no. 3 Q. If we go back, please, to the report, UBHT 52/264, and 4 turn over the page, to page 266, you then go on to deal 5 with data analysis. 6 Firstly, can I ask, what comparative data was your 7 analysis based on? Was it the Cardiac Surgical 8 Register? 9 A. I believe so. I think that they had produced some data 10 from the register at the time, yes. The report is based 11 on data we received at the time of the visit, nothing 12 else. We did not look at any other data at the time. 13 Q. Including the Cardiac Surgical Register, then? 14 A. You mentioned a register of 1991, which I have not seen, 15 as I said already before twice. 16 Q. I think that was intended to be a Bristol document 17 rather than -- 18 A. Yes, but I have not consulted that document to write 19 this report. Again, Dr Hunter may remember about the 20 register, but I am not aware of it. 21 Q. Did you consult the CSR to write this report, or was 22 your knowledge of comparative figures based on your own 23 experience and knowledge? 24 A. No, I did not use any of my own experience, I used only 25 the data which had been given to us at the time. 0070 1 MISS GREY: Sir, I am coming to the conclusions of the 2 report and then to its treatment. I wonder whether this 3 might be an appropriate moment to break for perhaps 4 three-quarters of an hour so that we might resume at 5 2.00? 6 THE CHAIRMAN: Yes, shall we do that, then? 7 (1.15 pm) 8 (Adjourned until 2.00 pm) 9 (2.00 pm) 10 MISS GREY: Could we scroll up, please, to page 266, 11 where you say, towards the bottom of the page, that 12 consultant 2 has a mortality of 0 per cent for VSDs, 13 0 per cent for tetralogy of Fallot and 8.6 per cent for 14 AV canal and as a result of that data, you say that 15 consultant would certainly compare very favourably with 16 the best UK institutions. 17 Consultant 2 was the consultant concerned with the 18 arterial switch operation; is that not right? 19 A. That is right, yes. 20 Q. So in making your judgment on comparisons, that was 21 excluding the switch series; is that right? 22 A. Yes. That was specified in the report somewhere, that 23 the comments were leaving the switches aside. 24 Q. If we go over the page, we see more generally your 25 conclusions about standards. 0071 1 Perhaps we should go back first to the previous 2 page, 266, please. You had been saying, in discussing 3 them, in effect that a number of the cases were "high 4 risk", is that right, or had complicating factors? 5 A. That is what the switch is. I indicated that one had an 6 undiagnosed coarctation of the aorta; two had the whole 7 coronary system arising from one sinus; and one of them 8 an intramural pathway. I said earlier two today, but it 9 is only one. 10 Q. On the next page you talk about multifactorial reasons 11 for failure for those particular results. 12 If we turn down the page, when you say that the 13 results of the neonatal arterial switch should improve, 14 that you were not able to determine the cause of those 15 poor results; is that correct? 16 A. That is correct, yes. 17 Q. And you say it is most likely to be a multifactorial and 18 multidisciplinary problem. What were you getting at in 19 that conclusion? 20 A. I indicated earlier that the diagnosis of the coronary 21 arterial pattern was not as good as could have been; 22 that coarctation was not diagnosed in those patients. 23 We already discussed the post-operative management of 24 those patients, which is the reason for using the words 25 "multidisciplinary" and "multifactorial". 0072 1 Q. What about the non-neonatal switch series? Where were 2 your conclusions or judgments on that to be found? 3 A. I did not comment very much on this because it is very, 4 very difficult to comment on those switches. If they 5 are older it means usually they have additional lesions 6 and therefore that they are actually technically higher 7 risk patients, and I think each of them has to be taken 8 individually. 9 The fact that the older switches which probably 10 were more complex had better results than the neonatal 11 switches to me would indicate that there was a problem 12 about doing open-heart surgery in new-born infants 13 there, because they had better results with older 14 patients. 15 I alluded to that problem when I was here a few 16 weeks ago, that many centres have progressed by lowering 17 the age of the patients on which they were doing 18 surgery. What Castaneda has done -- we mentioned him 19 earlier -- was he decided that those patients should be 20 operated on as neonates and set up a system which was 21 proficient at dealing with neonates. The problem with 22 some centres such as Bristol, or actually Great Ormond 23 Street, is that we have lowered the age and for quite 24 some time we felt that the risk of surgery in a bigger 25 patient was lower than in the younger infant, which is 0073 1 not the case if you have a system which is efficient in 2 dealing with small babies. 3 Q. The immediate trigger for the investigation you were 4 conducting had been a non-neonatal death in the switch 5 series. Do you think in the circumstances it was 6 adequate to produce a report without a clear guidance or 7 judgment on the problems or difficulties or results in 8 the non-neonatal switch series? 9 A. Well, two points. The first one is that we had not 10 received the details of the non-neonatal switches, so 11 far as I recall; I think we had seen only the details of 12 the 13 patients, and I do not believe that it is 13 possible to make a statement on the older ones without 14 more details for each single patient. I think each 15 single note should be reviewed. 16 Q. You said two points; were those them? 17 A. I think they were, yes. 18 Q. If we turn to page 268, we see at paragraph 8 that you 19 believe that it would be inappropriate to do neonatal 20 arterial switch operations before the new appointee took 21 up his position, but then you went on to say that you 22 had no reason to believe that Mr Dhasmana should not 23 continue to carry out operations on other conditions. 24 In what status did that recommendation leave the 25 position of non-neonatal switches? 0074 1 A. I do not think that sentence was a sentence which 2 indicates he could carry on the older switches. I think 3 we had identified a problem with the neonatal switches 4 and the comment is dealing with that particular subset 5 of patients; it does not mean that we think he could 6 continue to do the older ones. 7 Q. So your interpretation of how you intended your results 8 to be read was that all arterial switches should cease; 9 is that correct? 10 A. Well, I do not specifically comment on the older ones. 11 I think we were presented with a problem with the 12 neonatal ones. For that particular group of patients, 13 we thought it was inappropriate to continue. 14 Q. Does that mean the older arterial switches could 15 continue, or not? 16 A. I do not think I had an intention to comment on those 17 patients precisely because, first of all, it is very 18 uncommon to have to do a non-neonatal switch. It is 19 a very rare thing to do. I suspect some of those 20 patients had been banded in the past and it was an 21 operation which was no longer done for transposition. 22 So I think that the subset of non-neonatal switches is 23 very small in that group of patients. 24 Q. What do we take out of paragraphs 8 and 9? Do we take 25 out of them the fact that non-neonatal switches were 0075 1 envisaged as continuing if such a case should present 2 itself, or not? 3 A. No, I have not commented on the non-neonatal switches, 4 and I think, as I say, it is a group of patients which 5 are very, very rare, and I do not feel I should comment 6 on those patients more than any other patients. 7 Q. It was a crisis relating to a non-neonatal switch which 8 had been the trigger for your review. Is it 9 satisfactory to complete a review without offering 10 guidance on that situation should it present itself 11 again? 12 A. I think that most of the discussion was about the 13 neonatal switches. The switch is an operation which is 14 done in neonates, in more than 90, 95 per cent of the 15 cases, and although I agree that the visit was triggered 16 by a death following a switch which happened to be 17 a non-neonatal switch, I do not think that I wanted to 18 comment specifically on those patients who are older 19 than one month of age to complete the report. 20 Q. Can we go back to the preceding page where you discuss 21 the results for consultant 1. Perhaps to give it 22 a context, we should first look back at page 266. 23 If we scroll down, we can see consultant 1 has 24 a mortality of 0 per cent for ventricular septal 25 defects. 0076 1 Does that judgment imply a discard of the results 2 that Dr Bolsin had given you for that particular type of 3 lesion? 4 A. I think that those were the data for the periods 5 January 1992 to January 1995, produced by the surgeons. 6 Q. So when you said then that consultant 1 would be amongst 7 the higher risk surgeons, on what was that judgment 8 based? 9 A. On the AV canals, and I think tetralogy of Fallot as 10 well, in those days most centres, I think, I am not 11 sure, had lower mortality than that. But I am not 12 certain. 13 Q. Having made that judgment on consultant 1, you then went 14 on to make conclusions which we have looked at, if we go 15 back to page 268, which related to the cessation of 16 arterial switch operations, or neonatal arterial switch 17 operations before the new consultant took place, but you 18 did not make any comment as to what the position of the 19 first consultant would be until Mr Pawade came. Why was 20 that? 21 A. I think that the appointment of Mr Pawade had been made 22 and his coming was imminent, and surgeon number 1 had 23 already indicated that he would step down, so he is 24 a paediatric surgeon. 25 Q. Were you told when Mr Pawade would be coming? 0077 1 A. I think we were told, but I have forgotten what the date 2 was, I must say. 3 Q. I think the date was to be May 1995, so at least two 4 months from the date at which you were reporting. Was 5 there not a need to offer advice on the position of 6 Mr Wisheart in the interim? 7 A. I do not think I would have gone so far with the data 8 I had been presented with on that day. I think that 9 maybe you could have said that we should investigate 10 further the actual performance of Mr Wisheart to decide 11 what he should do while waiting for Mr Pawade to start, 12 but I do not think that I would have, on the data 13 available on that day, made such a recommendation. 14 Q. You said that you might have recommended that there was 15 a need for further investigation? 16 A. Yes. 17 Q. Why do we not find that in the report, then? 18 A. Because I think that that report, as I said earlier, was 19 to be given to the Chief Executive who had then to use 20 it as an indication of what the next step should be, 21 which, in my view, would have been for them to 22 investigate the overall problem, including the 23 performance of Mr Wisheart. 24 Q. But we do not see anywhere in your final conclusions 25 that further investigations of Mr Wisheart's position 0078 1 would have been desirable. 2 A. No. The report says that Mr Wisheart had agreed to step 3 down in the near future, which was, as you indicate, two 4 or three months later, and we qualify him as a high risk 5 surgeon, so I thought those two comments were sufficient 6 for the Chief Executive to decide what the next step 7 should be. 8 Q. If we go back to page 267, to the top there, you make 9 comments at paragraphs 2 and 3 about the absence of any 10 data to provide definitive national benchmarks against 11 which the performance of the surgeon can be set. We 12 discussed the availability of the Cardiac Surgical 13 Register. That is one benchmark, is it not? 14 A. It is, but it gives the UK figures which are not 15 validated on the one hand, so we do not know what the 16 performance of each individual unit or individual 17 surgeon is, which I think is very, very important. Let 18 us assume, which I think is the case, that there are in 19 the UK maybe three centres doing more than 400 or 20 perhaps 500 cases per year, and then that there are 21 10 or 15 units doing a very small number. If the three 22 large units have good results, the average of the UK 23 register will be probably a lot higher than those who 24 are the poorer performers. 25 So I think it is very, very difficult to say that 0079 1 in terms of number of surgeons, the two surgeons at 2 Bristol, one was below the average performance of other 3 surgeons in the UK at the time. 4 Q. What about other sources of data that would have been 5 available to practitioners at the time: papers, for 6 instance, commenting on performance? 7 A. By and large, people like to publish their good results, 8 not their bad results. You could rely on those results 9 to establish a benchmark if you decide that the 10 benchmark should be based on the best published results. 11 That is fair enough, but you cannot consider that it 12 represents what goes on in the field at the time. 13 Q. If you are trying to judge what is going on in the 14 field, what about the informal discussions that one has 15 with colleagues, other people in what is a relatively 16 small field? Is that not a way of finding out what the 17 experience of other institutions is? 18 A. I do not believe so. I think that people have 19 a tendency to either exaggerate or forget their 20 problems, and unless you have hard data, it is 21 impossible to compare. 22 Q. Looking at the picture overall, would you say it was 23 not possible, then, to set parameters against which 24 acceptable performance could be judged? 25 A. Certainly not at that time, and even today I would have 0080 1 some difficulties in telling you what we should do to 2 compare the performance with. 3 Q. We have looked at the report that you produced, and we 4 have seen that it was faxed through to Dr Roylance on 5 23rd February. You say in your statement that 6 unfortunately there was nobody there to receive it, 7 despite having enquired, so as to hopefully ensure that 8 that would take place. 9 Can you tell us, Professor, what was the status, 10 as you understood it, of the report that had been faxed 11 through to Dr Roylance? 12 A. It was a document which was sent to him to help him 13 understand the problem, find out if there was a problem 14 or not and help him to solve it to take action. 15 Q. Was it a completed report, or was it a draft on which 16 you expected further discussion and comment? 17 A. We have used the word "draft" to justify that document. 18 The main reason for changing the document was that we 19 did not expect this document to be part of the public 20 domain as it stood. 21 Q. But when you say that you used the word "draft" to 22 justify it, are you saying, therefore, that you apply 23 that word because it was intended to be confidential and 24 therefore the analysis was not, perhaps, particularly 25 robust, as opposed to using the word to describe 0081 1 a document upon which you expected comment, criticism, 2 further feedback, and expected to revise it in the light 3 of, say, comments from clinicians? 4 A. I think that the truth is that I did not expect to have 5 to change the document if it had remained within the 6 knowledge of the Chief Executive. 7 The reason for changing it is that the nature of 8 the document had changed, in my view, after it had been 9 sent to the Chief Executive. 10 Q. Because we learned that it was seen by other clinicians 11 in a semi-open meeting? 12 A. Yes, that is correct. 13 Q. What were you told about what had happened to it? Can 14 you tell us firstly, who reported back to you on this? 15 A. I think, but I am not sure, it was Mr Wisheart or, is it 16 Mr Nix who was at the time the Deputy Chief Executive? 17 Q. That is correct, he was Deputy Chief Executive. 18 A. Because Dr Roylance was on leave of absence, so I am 19 pretty sure that Mr Wisheart had telephoned me and 20 I think Mr Nix as well, and explained to me what had 21 happened. The document had been read at a meeting and 22 therefore was now a public document. 23 Q. Was any comment made to you about the advisability or 24 otherwise of releasing or publishing the document as it 25 first stood, by either of them? 0082 1 A. I think that both of them indicated that in the wording 2 of some of the sentences, it was not appropriate -- 3 I forget the word they used -- or we did not have enough 4 data to support them for a public document. 5 Q. Can you recollect the phrase "legally inadvisable" being 6 used to you? 7 A. No, I do not recall that. 8 Q. Or any suggestion that there had been legal advice 9 taken? 10 A. I did. When I realised that the document had been 11 displayed publicly, I went to see my own Chief Executive 12 to find out what I should do, and he advised me to take 13 advice to the hospital legal adviser who asked me 14 whether I had indicated on the document that it was 15 confidential and I said "No". He said "In that case you 16 cannot say that it was confidential". 17 Q. People who contacted you -- Mr Wisheart, Mr Nix -- so 18 far as you can recollect, were suggesting that various 19 amendments might need to be made to the report? 20 A. Yes. 21 Q. Did those suggestions come from both of them, or either 22 one or other of them? 23 A. I forget the details. The only thing I recollect is 24 that I refused to change the actual content of the 25 report, but I was prepared to change part of the 0083 1 wording, if it had been somewhat too strong, but the 2 nature of the content was to be the same. 3 Q. Can you remember who it was who was suggesting 4 amendments in the draft to you? 5 A. No. I mean, as I say, I spoke to both of them and 6 I have forgotten the details of the discussions. 7 Q. Did anybody ever fax to you, or send to you, any 8 comments in written form on your draft? Or was this all 9 done over the telephone? 10 A. No, I do not recollect receiving -- and I went through 11 my records; I do not recall receiving any fax. 12 Q. So if I showed you, for instance, UBHT 61/370, where we 13 see at the top the response to the document and then the 14 response is said to summarise conclusions of Dr Joffe, 15 Dr Monk, Professor Vann Jones, is that the first time 16 you have seen that? 17 A. Yes, the first time. I have not seen that, no. 18 Q. Let us take it down, then, and go back to the final 19 version that was completed. 20 First of all, can you help us on the date when it 21 was completed? If we look, please, at PAR(2) 1/105, 22 this, I think, is the final version of the document; 23 is that right? The double-spaced version. (Pause). 24 A. From my records here, the last word on page 1 appears to 25 be -- 0084 1 Q. We can look at various versions it. If we look at 2 PAR(1) 5/130, this is a slightly better copy. Do you 3 see at the bottom of the page what you were looking 4 for? It simply says "currently provided ..." 5 If we turn over the page, please, you see there at 6 the bottom of that paragraph the discussion of the 7 post-operative care: 8 "The overall post-operative management at the 9 Royal Infirmary appears to be less organised with 10 multiple decision-making processes." 11 Does that help you to identify the document we are 12 looking at? 13 A. I have probably made a mistake here. That must be the 14 last report, I suppose. I have the first one here. 15 Q. Are you happy to say -- 16 A. I am happy to say this is the second one, yes. 17 Q. Perhaps we can go back to the version I was showing you 18 first, PAR(2) 1/105. I just wanted you to look at the 19 top there, because we have a fax number and then a very 20 faint date which, if we look at the top left and also 21 the date stamp, it appears to suggest that it is 22 28th March? 23 A. Yes. 24 Q. Would that be when the final version was sent through by 25 you to the Trust? 0085 1 A. I had a thank-you letter from the Chief Executive which 2 was dated -- 3 Q. There is a letter at UBHT 61/340. That is a reference 4 to the first version coming through. That would not be 5 what you are referring to? 6 A. No. I think that Mr Nix sent me a letter to thank me 7 for the report. 8 Q. Perhaps we can find that and come back to it. In the 9 meantime, if we can just go back to that version -- 10 A. Mr Hugh Ross sent Mr Nix a letter on 15th March 1995 to 11 acknowledge he received the report. 12 Q. Would that be the final version of the report, then? 13 A. It would have been, yes. 14 Q. If we could go back, please, to PAR(1) 5/230, and go 15 through, if we may, the different -- 16 THE CHAIRMAN: We are going to see that letter in due 17 course, are we? 18 MISS GREY: I hope so. If we look, if we may, at the 19 changes that were made to the report, the first one 20 is over the page, page 131, please. I am sorry, 21 I think the reference is poor there. It should be 22 PAR(1) 5/131. You made a slight change about five lines 23 down in the respective roles of Mr Wisheart and 24 Mr Dhasmana, making the point that Mr Dhasmana had taken 25 over the great bulk of the paediatric practice since 0086 1 Mr Wisheart became Medical Director of the Trust? 2 A. Yes. 3 Q. Was that information provided to you since the first 4 report was completed? 5 A. I do not know when the first report was ... 6 Q. We can bring it up on the split screen, if you want to 7 put up UBHT 61/356, please, and turn down to "Current 8 Paediatric Cardiac Services", you see on the left-hand 9 side of the screen the fact that it is noted that the 10 latter, i.e. Mr Dhasmana, seems to have taken over the 11 greater bulk of the paediatric practice and then you add 12 in the second report, "since Mr Wisheart became Medical 13 Director"? 14 A. It must have been some information I received 15 afterwards. 16 Q. At the bottom of the second version, if we can keep the 17 split screen version, please, we see, towards the bottom 18 of that substantial paragraph, that there is 19 a substantial change, if I may describe it as such, in 20 the description of the overall post-operative management 21 at the BRI? 22 A. Yes. 23 Q. Can we highlight the last few letters? If we turn over 24 the page on the split screen, you have seen that the old 25 version had "the overall post-operative management at 0087 1 the Bristol Royal Infirmary appears to be", and then you 2 wrote "highly disorganised with conflicting decisions 3 between ...", if we can enlarge that. 4 The second version -- the two are now 5 contrasted -- is considerably softer in its tone, is it 6 not? 7 A. It is, yes. 8 Q. Why did you make that change? 9 A. We discussed earlier the information received about the 10 post-operative care was from Miss Thomas, and 11 I indicated earlier today that if what she said is 12 correct, I would maintain that they were highly 13 disorganised. 14 I do not think it is fair to again have a public 15 document which is making a very strong comment on the 16 way the intensive care unit is functioning without 17 having this confirmed by the people most involved with 18 the patients, who are the anaesthetists, the surgeons 19 and the cardiologists and intensivists, I think. 20 Q. So what had been conveyed to you that led you to make 21 that change, what had been said to you? 22 A. As I said, I spoke with Mr Wisheart and Mr Nix after the 23 first report, some discussions I think over the 24 telephone, not in writing, that I have to make some 25 amendments. 0088 1 Q. If we can just go back to the issue of some letters from 2 Mr Nix to yourself and look at UBHT 61/341, please. 3 Is that the letter that you had in mind? It is 4 dated, if we scroll up again, please, 7th March 1995. 5 A. Yes, I think that is the one. 6 Q. If we go on, please, there is a further letter on the 7 15th -- 8 A. The 15th is the one I referred to. 9 Q. UBHT 61/342, where they sent a protocol. Since we are 10 on it at the moment, if we look at page 344, that is 11 your response approving the protocol that had been sent 12 to you? 13 A. Yes. 14 Q. So would it be right to conclude from that exchange of 15 letters that the amended report had been sent through to 16 Mr Nix prior to the 7th March, which is the first letter 17 we saw, if we go back to it, at 341, please? 18 A. Well, probably. I could not find the exact date of my 19 sending that report, I must say. 20 Q. If we go back, then, to the text of the report, 21 PAR(1) 5/131, please, you also added a new sentence: 22 "Consultant surgeons appear to have the last say 23 in the management". 24 Was that on the basis of new information provided 25 to you, or was that always your perception? 0089 1 A. I forget why I added that sentence. It must have been 2 from some discussions, but I forget the reason for 3 deciding to change that. 4 Q. If we move on, the background of the current problem, 5 there is a small change in that you refer to the 6 calendar of events provided by Dr Bolsin at a different 7 point, which one presumes was to make the matter a more 8 logical account; is that right? 9 A. I am sorry, what is the change I made there? 10 Q. If we look at the old version at UBHT 61/357, we can see 11 that towards the bottom, "Background of Current 12 Problems", there is the reference to the calendar of 13 events being obtained in part from the interviews, but 14 it is at the bottom, most of the way through your 15 chronology rather than being at the top of it as we find 16 in the new report. 17 A. Yes. 18 Q. Would I be right in thinking that is merely a change? 19 A. I suppose it is more logical a timing, I suppose. 20 Q. The next change we can note is that if we look, please, 21 to page 132 of PAR(1) 5 again, we see that the auditing 22 showed that the results of the arterial switch operation 23 were poor, and the results of Bristol for far more 24 classical conditions such as tetralogy of Fallot, 25 AV canal and VSD were worse than the national average. 0090 1 If we look back at UBHT 61/357, we would see that 2 there was an addition there that one surgeon had results 3 statistically worse than the other? 4 A. Yes. 5 Q. That has now been omitted. Why was that? 6 A. Because -- again, I am speaking now from recollection, 7 but I think that the first version of the report was too 8 strong compared to the weakness of the data I had and 9 the lack of good statistical analysis. 10 Q. If we turn down to the next page of the report, 11 PAR(1) 5/133, and go, please, to the bottom of the page 12 under the section "Forward planning", can we go split 13 screen and put up UBHT 61/358 on the other side? 14 There are two changes there: firstly the reference 15 to Professor Peter Fleming has been dropped. Can you 16 tell us why that change was made? 17 A. I suspect that what we had indicated in the first report 18 was not confirmed, was not correct. I do not see any 19 other reason for removing that particular sentence from 20 the report. 21 Q. And then if we go on, Mr Pawade's appointment had been 22 described as having been with the intention of putting 23 him in charge of complex and neonatal paediatric cardiac 24 surgery, but now the report says merely he will 25 "contribute to the future development" of these types 0091 1 of surgery. 2 What lay behind that change? 3 A. Again, we have not seen Mr Pawade's contact and the 4 information we received about his position was perceived 5 as being at the head of a programme during the visit and 6 that this was to be rediscussed before writing the 7 second report, indicating that his position was not 8 necessarily to be the head of department or section. 9 Q. If we turn over the page, again, this is the forward 10 planning stage. You have now put in a new reference or 11 changed the reference to Mr Wisheart's plans of dividing 12 his activity between adult cardiac surgery and 13 administration. You have put that into the section on 14 forward planning. Would that be to reflect a perception 15 that that change had already been planned as opposed to 16 being a change that was in response to recent events? 17 A. Our understanding was that the plan had been made at the 18 time of the visit. 19 Q. If we go on, please, to the data analysis on page 135 20 and take, really, this matter broadly as a whole, 21 because the overall change that is made in the data 22 analysis, and indeed the conclusions and perceptions, is 23 that the references to Mr Wisheart as being a higher 24 risk surgeon, and in general the focused criticisms of 25 Mr Wisheart's performance, are omitted from the final 0092 1 report. 2 Can you explain to us why that was done? 3 A. Yes, because I feel that we did not have scientific data 4 to support such a strong statement. As you know, it 5 takes several months for the General Medical Council to 6 reach a verdict about this, and I do not see how, in all 7 fairness to him, we could have reached a judgment in one 8 day. I think it was unfair to have a statement like 9 this made public without further analysis. 10 Q. But if you had reached an adverse conclusion, at least 11 provisionally on the basis of a confidential report, and 12 you were considering withdrawing that from a further 13 report, was there not a case at least for recommending 14 that further investigation needed to be taken into these 15 particular results? 16 A. I do not think the two reports are contradictory. 17 I think they are reports which express the same views 18 with a different level of certainty. I think that our 19 remit was to give an opinion to the Chief Executive and 20 I think that the report was clear enough to indicate 21 that there was a need for further investigation. 22 Q. But where do we find in the second report, a reference 23 to the fact that the results for the AV canal in one 24 surgeon were such as to have caused you concern at the 25 first visit? 0093 1 A. I thought that I had commented on the AV canal in the 2 second report as well. 3 Q. We can read through page 135, if we scroll down that 4 page gradually. "The second state of data ..." and it 5 then goes on to deal with the arterial switch and the 6 remainder of that page is to deal with that. 7 If we turn over the page, we see a discussion of 8 good results at the Children's Hospital. Then we see 9 the results of various operations repaired by 10 Mr Dhasmana, including AV canal, but no discussion of 11 the adverse results in Mr Wisheart's series? 12 A. I thought I had left them in. I think they should have 13 been left in. I thought I had done so. I thought I had 14 left it in, but obviously not. 15 Q. I will be corrected if I am wrong, but I think we will 16 find that there is no reference to adverse results in AV 17 canal in the second version of the report. 18 If we turn in particular to the conclusions and 19 recommendations, looking at page 137, we see there 20 references to "improvements", a more lengthy discussion 21 of the arterial switch procedure -- say when you are 22 ready to turn the page. 23 A. Yes, I am. 24 Q. Over the page, Mr Dhasmana's position as a "spare 25 wheel". 0094 1 A. Yes. 2 Q. Then paragraph 4 is in relation to communication between 3 the various departments and the need for audit 4 meetings. 5 Paragraph 5, "alleviation of tension", and then 6 the position in the interim at the bottom. 7 We turn over the page: again, a reference to the 8 question of the arterial switch repair. There appears 9 to be nothing there on the AV canal. 10 Would it not have been appropriate to have 11 included something on the need for further 12 investigation? 13 A. Not necessarily on the need for further investigation, 14 but I think I should have left in comments on the poor 15 results for AV canal requiring full investigation. 16 Q. Because if this report was to be made public, was it not 17 important for patients in particular to have access to 18 that sort of data so as to enable them to judge? 19 A. I am confident that if we had submitted the data 20 available to us to a statistician, that statistician 21 would have taken out the comments I had made in the 22 first report. 23 Having said that, I think that I could have 24 indicated some concern at least in this report; I agree 25 with that. But I certainly believe that we did not have 0095 1 enough evidence to make the statements I made in the 2 first report. 3 Q. Or, with the benefit of hindsight, perhaps you might 4 agree that you might have indicated, in this report, the 5 need for further investigation, further data, if the 6 existing data that you had was not robust enough to 7 reach the conclusions -- 8 A. Yes, I agree. 9 Q. Looking at the matter now, Professor, what is your 10 overall conclusion on how robust both reports were, and 11 whether or not they were appropriate at the time they 12 were written? 13 A. I think they were appropriate. I think they are as 14 robust or as weak as the data we received to make the 15 report. We certainly agreed that there was a problem. 16 We commented on ways to alleviate some of those problems 17 and make recommendations for the future based on the 18 decision that the Trust had already made when we visited 19 them. But I think that the strengths or the weaknesses 20 of the report is parallel or relates to the strengths or 21 weaknesses of the data that we had. 22 Q. If we go back to page 137 of the new report, you have 23 amplified the discussion of the arterial switch, 24 paragraph 2. You talk about it being a multifactorial 25 and multidisciplinary problem. Are you able to help us 0096 1 on the multifactorial issues that now, particularly with 2 the benefit of your work on this area, you would think 3 were important in the difficulties that were being 4 experienced with those series? 5 A. I believe so. My recent analysis of more than 200 6 switches in the UK has confirmed that a number of 7 transpositions are at higher risk than others, and 8 mainly this depends on the coronary arterial 9 distribution. But if you take account of the anatomic 10 variance and you try to analyse the human factors of 11 what I have called minor and major failures or events 12 related to those who perform the procedure and who are 13 involved in the treatment, those have a major, major 14 impact on the outcome. I think that the wording of the 15 conclusions that we were making in 1995 reflect what the 16 study has shown now. 17 Q. You have spoken in your study or work more generally of 18 the importance of "mental readiness" in surgery? 19 A. Yes. 20 Q. What importance do you think that factor had in the 21 context of events at the BRI? 22 A. I alluded to this earlier. I think that personally 23 I would have been unable to carry on with the pressure, 24 the tension which surrounded the results of the arterial 25 switch at the time. For example, personally, I would 0097 1 not even have accepted to have a meeting for the last 2 switch because, even if the statistics indicated that it 3 was acceptable medically, I think I would have been 4 unable to do it, mentally, myself. 5 Q. Do you think that the peri-operative situation with the 6 input of cardiologists and the post-operative situation 7 in relation to the ability of cardiologists to 8 contribute to care were factors you would like to 9 comment on? 10 A. I believe that it is very important to have 11 cardiological support at all times. Obviously 12 throughout the management of those patients, the 13 cardiologist plays the major role to begin with, than 14 the surgeons, and then the cardiologists again later, 15 but throughout that period I think the two teams must be 16 available and complete each other. It is fairly common 17 for us to call in the cardiologists in the operating 18 theatre to give advice, or to share a problem and try to 19 solve it together. 20 Q. You have written about the responses of teams to crisis 21 and how they react under pressure. 22 In your visit to Bristol Royal Infirmary, how do 23 you think that particular team responded to pressure? 24 A. As I said earlier, we have not questioned the role of 25 the working relationship between anaesthetists and 0098 1 surgeons, for example, but I must say, if there is, 2 while you start an operation, a conflict already between 3 the anaesthetist and the surgeon, knowing for example 4 that the anaesthetist is there as a policeman watching 5 what you are doing, calculating your clamping time, 6 et cetera, it is certainly a very strong negative event 7 in terms of having an impact on the outcome. And we 8 have demonstrated that. We have demonstrated that the 9 relationship between teams does have a major impact on 10 the outcome. 11 Q. In your statement you write: 12 "Dysfunctional teams are often underlying poor 13 institutional performance and this was perceived during 14 our visit in February 1995." 15 What did you mean by "dysfunction"? 16 A. Precisely the relationship between anaesthetist and 17 surgeon was not satisfactory. The intensive care unit 18 was not satisfactory. There were several teams involved 19 in the management of those patients without any 20 co-ordination in the unit. 21 MISS GREY: Thank you very much. Sir, I have reached the 22 end of the questions I would like to ask, subject to 23 this: we have just received a number of comments from 24 Mr Wisheart, which again, no fault with him as to the 25 date and time they have been provided to us. I might 0099 1 suggest that the Panel should commence questioning now 2 while I look at them, or perhaps more helpfully, if we 3 could break for five or ten minutes and then resume, 4 with the aim of starting Dr Hunter's evidence 5 immediately after Mr de Leval ceases? 6 THE CHAIRMAN: Just to understand, you are suggesting 7 a short break for Professor de Leval to see those 8 comments and be asked about them? 9 MISS GREY: Indeed, yes. 10 THE CHAIRMAN: Yes, I think that would be appropriate. 11 Shall we say a maximum of 10 minutes, but subject of 12 course, in fairness to Professor de Leval, if you need 13 more than that, you will let us know through Miss Grey. 14 (2.55 pm) 15 (A short break) 16 (3.05 pm) 17 MISS GREY: There are just a few supplementary points 18 I would like to raise with you, Professor, if I may. 19 Firstly, just a supplementary question on the 20 changes to the first report in relation to Mr Wisheart 21 and the data in relation to him. 22 Can you recollect exactly what was said to you 23 that led you to alter the report in relation to that 24 aspect of it, i.e. Mr Wisheart's AV canal data? 25 A. I had at least one or two discussions afterwards and 0100 1 I believe it was mainly with Mr Nix. I went through the 2 report on the telephone, and agreed to amend what we 3 felt was too strong; we had not enough evidence to make 4 those strong comments, and the AV canals was part of it, 5 I think. 6 Q. Can you remember what Mr Nix was saying to you? 7 A. No, I do not remember. 8 Q. If we can go then, please, to your statement, 9 WIT 319/2, if we scroll down the page, please, you talk 10 about "pitfalls of the reports", and at the last 11 paragraph there you talk about the 1990 to 1995 results 12 you received, to write a commentary. You now regret the 13 data had not been individualised. With hindsight, you 14 should have made that request. 15 Can we be clear about this: this is a reference to 16 in effect a third report written by you in the form of 17 a commentary written in late 1995/early 1996; is that 18 right? 19 A. That is correct, yes. 20 Q. If we look at UBHT 52/97, is that the report we have 21 been discussing? 22 A. Yes. 23 Q. We have seen you have written an independent 24 commentary. Did you have a commissioning letter for 25 that report? 0101 1 A. I am not sure. I know that that took place with the 2 Chief Executive at that time. 3 Q. Perhaps rather than take time on it now, could I ask you 4 to look, Professor, to see whether you had 5 a commissioning letter and if so, could you provide 6 a copy to the Inquiry? 7 A. Yes. 8 Q. Do you know why you were involved in writing that 9 independent commentary but Dr Hunter was not? 10 A. No, I do not, I am afraid. I do not think I questioned 11 it. They asked me if I would accept it and I accepted 12 it. I did not even know if I was the only person to 13 write a commentary on this or not. 14 Q. We have received, as I said, the comments of Mr Wisheart 15 on your statement. He has commented on the part of the 16 statement that we have just looked at, if we go back to 17 319/2, please, where you had set out an expression of 18 regret that the data had not been individualised. 19 Mr Wisheart's comment is that he wishes to make it 20 clear that the data presented to him, Professor 21 de Leval, by the surgeons on 10th February 1995 was 22 individualised. 23 Firstly, that is correct as a statement of fact, 24 is it not? 25 A. It is correct, yes. 0102 1 Q. "Professor de Leval asked Mr Dhasmana and myself to 2 provide him with the full surgical results of all 3 paediatric cardiac surgery for the years 1992 to the 4 beginning of 1995." 5 Mr Wisheart there, it is apparent, is setting out 6 his recollection of a request by you to him? 7 A. Yes. 8 Q. Is he likely to be right about that? 9 A. Probably. I said this morning I did not recollect 10 having requested any data before, but I would accept 11 what he says and I probably have forgotten about it. 12 I did not put it in writing, that is for sure, but 13 I probably asked on the telephone. 14 Q. He continues: 15 "Although we have not been asked specifically to 16 produce data for individual surgeons, we did do so. The 17 full set of tables which we presented to Professor 18 de Leval and Dr Hunter may be seen in the GMC documents, 19 the Chief Executive's file pages 74 to 80; on pages 77 20 and 78, the surgeon specific results for open-heart 21 surgery in those over and under 1 year of age are 22 presented." 23 I think from what you have already told us in 24 evidence, you would agree with that as an accurate 25 comment? 0103 1 A. I do, and we commended the surgeons for having done so 2 at the time. 3 Q. He also comments, looking at your statement at page 3, 4 please, at paragraph N4, where you set out there your 5 recollection that it was only in 1993 that the results 6 were reviewed at a joint meeting of cardiac surgeons, 7 paediatric cardiologists and cardiac anaesthetists. 8 Mr Wisheart's comments are that: 9 "In this part of his statement, Professor de Leval 10 appears to be summarising information provided to him by 11 Dr Bolsin. It would seem that it was suggested to 12 Professor de Leval that there would be no joint review 13 of surgical results until 1993. I do not remember 14 whether Professor de Leval and Dr Hunter asked us 15 questions about this or our audit's activity generally." 16 Are you able to help on whether you can recollect 17 such questioning? 18 A. No, I do not recollect this. Again, perhaps Dr Hunter 19 does, but I do not recollect having received a list of 20 seven audit functions taking place in the department as 21 early as 1984, which I am sure is correct, it is true, 22 but I do not think we had been informed of that at the 23 time of the visit. 24 Q. So when Mr Wisheart goes on, you might well agree with 25 him when he says: 0104 1 "It would therefore seem at least a possibility 2 that Professor de Leval and Dr Hunter were not provided 3 with the complete information about the preparation of 4 surgical data and the opportunities for discussing these 5 in joint meetings." 6 A. That is correct. 7 Q. Then Mr Wisheart says that he would like to clarify the 8 situation as briefly as possible and he sets out the 9 seven categories of information that he says were 10 available or were provided from 1984 onwards. 11 The first thing he mentions is that he says that 12 annual statistical summaries were prepared from before 13 1984. From 1984 onwards, in order to seek to neutralise 14 the problems arising from very small numbers of 15 individual operations, figures for each operation were 16 aggregated over the last four to five years, as well as 17 being given for the most recent year. The figures for 18 the most recently published UK CSR were also provided 19 for comparison. 20 He goes on, in paragraph 2: 21 "These were usually considered by the whole team 22 at multidisciplinary evening meetings, but Dr Bolsin 23 only became an occasional attendee of these after 24 approximately 1991. These meetings were the best 25 opportunity for surgeons, cardiologists and 0105 1 anaesthetists to meet." 2 Firstly, is that new information to you? 3 A. It is completely new. I must say that point number 1, 4 the annual statistical summaries, we do not have them 5 today at Great Ormond Street. I am sure that whatever 6 was sent to us did not have that for 1984. The second 7 point is again totally new information for me, a vital 8 piece of information: at that meeting Dr Bolsin had to 9 tell them about his audit. I do not see how that could 10 have taken place without that issue being discussed, at 11 a meeting like this where they reviewed the results. 12 Q. We hear that Dr Bolsin became only an occasional 13 attendee, so presumably it may be still an open question 14 as to whether or not he was able to attend or did in 15 fact attend these meetings. 16 Mr Wisheart goes on to say that the same data in 17 a different form was returned to the UK Cardiac Surgical 18 Register from 1977 onwards; that there were regular 19 clinico-pathological conferences. And that there was an 20 audit programme in the Children's Hospital called 21 paediatric cardiological audit, which included 22 cardiologists, surgeons, radiologists, nurses, catheter 23 laboratory technicians and anaesthetists, but he does 24 not recollect any of the open-heart anaesthetists 25 attending. 0106 1 Can you comment on the frequency or difficulty 2 that might have been experienced by anaesthetists 3 attending meetings such as this, from your experience? 4 A. Yes, we had the same problem at Great Ormond Street. 5 Anaesthetists never attend our morbidity conferences 6 and -- I discussed this earlier -- it is because they 7 have other commitments; they are not committed only to 8 the cardiac work so they are often busy elsewhere and 9 cannot attend those meetings. 10 Q. He goes on to say that in effect the same problem arose 11 with cardiac surgical audit which began formally in 12 about 1990 and took place on a monthly basis, or 13 a monthly basis during term time, but the cardiac 14 anaesthetists had their own audit meeting at the same 15 time and therefore did not attend. 16 Finally, he goes on to mention various ad hoc 17 audit meetings, one in December 1992 following 18 Mr Dhasmana's first visit to Birmingham, which was 19 devoted to considering the switch operation. One in 20 December 1993 when Dr Hayes reviewed and presented in 21 detail the results of the neonatal switch operation, and 22 in January 1993, he writes: 23 "There was a one-off meeting attended by 24 cardiologists, anaesthetists and myself, but 25 unfortunately Mr Dhasmana was detained in theatre. This 0107 1 was doubly unfortunate because he was going to present 2 the audit. I think this was the meeting referred to by 3 Professor de Leval as the 1993 meeting." 4 Can I ask you, Professor, are these details new to 5 you? 6 A. They are new, yes. 7 Q. If accurate and correct, do they alter the comments that 8 you made about surgeons' reticence about providing data 9 in any way? 10 A. They do, certainly. 11 Q. Finally, the third comment by Mr Wisheart, over the 12 page, "Surgeons' data". He is looking at paragraph N6 13 of your statement here, where you commented that the 14 surgeons prepared the data only just prior to your 15 meeting with Mr Wisheart and Mr Dhasmana on 16 10th February. He refers back to the information I have 17 just summarised and also points out that you asked him, 18 with Dr Hunter, to prepare data less than two weeks 19 prior to the visit. 20 He then goes on to discuss the work required to 21 complete a data sheet for all open-heart cases, 22 approximately 450, that had been operated on during that 23 period and had to be done on top of his clinical and 24 other commitments: 25 "It was an immense task which we managed to 0108 1 complete with the assistance of Dr Martin and Dr Hayes. 2 It is certainly true that the preparation of that data 3 was completed on the evening of 9th February. Again, it 4 would appear that Professor de Leval and Dr Hunter may 5 have been given the impression that this data, completed 6 the night before, was the only data available. That is 7 not correct." 8 Is that something you are able to comment on, 9 Professor de Leval, firstly as to your impression that 10 this data, completed the night before, was the only data 11 available? Did you get that impression? 12 A. This is the impression we had, that was indicated by one 13 of the interviewees, I think the Director for 14 Anaesthesia, who had indicated that the data had been 15 available to him for the first time just prior to this 16 meeting. 17 Q. We can go back to that. We have, first of all, Dr Pryn, 18 WIT 319/16, please; where he says that he had suffered 19 from a lack of data, most of which he had only just seen 20 for the first time the previous day and Dr Monk, over 21 the page at the bottom: 22 "There had been unsatisfactory access to figures 23 until quite recently ..." 24 It would appear from that that there may be 25 a level of conflict amongst the various players 0109 1 concerned about access to data. Is that a fair comment 2 on what you have now seen? 3 A. There is a discrepancy between the information we 4 collected and received during the visit and what was 5 going on in the department. 6 Q. But realistically, Professor, you are not in a position 7 to help the Inquiry, I think, as to the truth or 8 otherwise of who had received what and when. 9 Finally, if I could go back to one matter, 10 Professor: Professor Angelini's letter, UBHT 61/338. 11 First of all, that letter assumes that there is 12 a problem in the paediatric work in the unit. It is the 13 background from which that letter is written. 14 A. Yes. 15 Q. Did you have any knowledge or understanding of what that 16 problem was, when the letter was written and received by 17 you? 18 A. No, none at all, no. 19 Q. He suggests that it may not be enough to have only 20 a day's visit, that in order to have a full picture, it 21 may take little more than a visit. 22 Did that ring any warning or alarm bells with you? 23 A. Absolutely, and that was discussed before I accepted to 24 come to pay the visit. I made it clear that I was not 25 able to do it for more than one day unless it was after 0110 1 my holiday, and they accepted that, so I had offered not 2 to do it because of time. 3 Q. Finally, the letter might be described as being one from 4 a concerned and dispassionate colleague. 5 Was that the way in which Professor Angelini 6 presented when you had an interview with him? 7 A. I think that he had reached a stage of being rather 8 aggressive vis-a-vis the other two surgeons and, I mean, 9 I had never met him before and I had never the 10 opportunity to see him in the other circumstances, but 11 I felt that he was rather hostile and aggressive when we 12 saw him. But it might have been just an indication of 13 desperation, I do not know. 14 MISS GREY: Thank you very much. I for my part have no 15 further questions. The Panel may have some. 16 Examined by THE PANEL: 17 THE CHAIRMAN: I have just one question, Professor 18 de Leval. I muse upon a point and seek to get your 19 judgment now. 20 Do you, with the benefit of hindsight, wish that 21 you had not agreed to prepare this report, or, putting 22 it another way, why did you agree to prepare this report 23 when the circumstances were clearly not propitious to be 24 able to say anything, as you soon discovered, which 25 might be valid beyond the very narrow range of 0111 1 validity? 2 Given the importance that has been attached to the 3 report, what are your views? 4 A. With hindsight, I think that it was only a mistake to 5 accept it, but in the current context, if I was asked to 6 be involved today in an independent inquiry about 7 a problem, with always the same type of pressure of 8 time, pressure of doctors who are temporarily suspended, 9 pressures of patients at risk, I think the time pressure 10 is always there and there is a conflict between that 11 pressure and the need for a scientist to assess data and 12 compare them. 13 I think that to some extent, to give an 14 independent report for such an important matter is 15 probably an impossible task. So I think that with 16 hindsight, I would probably have preferred not being 17 involved at all in this report, but looking at it 18 prospectively, I think that one should find a mechanism 19 whereby advice and opinion can be given at short notice 20 without major implications and without having to go 21 through the trauma that to some extent I went through 22 today, trying to help the situation. 23 THE CHAIRMAN: It was with a view to eliciting those last 24 observations that I really asked the question, because 25 in a sense, would you agree that the way you were caused 0112 1 to conduct your report was almost a perfect example of 2 human factor problems in so far as you were working 3 against the clock and you did not have enough time and 4 what we might be thinking of here, my colleagues and I, 5 as to how to engage in those sorts of activities in 6 a way which will produce something which can be helpful 7 for the future. 8 A. I think that I made a comment at the end of my report on 9 this. If evidence has to be based on statistics, first 10 of all we need casualties to do this and we need a large 11 number to be highly significant, usually. I believe 12 that using negative outcomes other than deaths, for 13 example, like the near misses have not been nearly as 14 full as expected, so that is not the solution yet. 15 I suggested in my report we should be proactive and have 16 programmes of outside reviews of the various 17 departments, to try to pick up problems before they lead 18 to accidents or casualties. 19 THE CHAIRMAN: Thank you very much indeed. There are no 20 more questions from us. I conclude by thanking you very 21 much indeed for coming again to talk to us and to help 22 us. We are very much in your debt. Thank you. 23 (The witness withdrew) 24 MISS GREY: Dr Hunter is also here to give evidence about 25 the same report. 0113 1 Dr Hunter, could you stand, please, to take the 2 oath? 3 DR STEWART HUNTER (SWORN): 4 Examined by MISS GREY: 5 Q. Dr Hunter, you have given a statement to the Inquiry 6 about the issue of your visit to Bristol to prepare the 7 report we have been discussing today. If we look at 8 WIT 322, please, page 1, is that the first page of the 9 statement you prepared? 10 A. It is. 11 Q. If we turn, please, to page 8, there is, at the bottom 12 there, the rubric "Prepared but not signed by Stewart 13 Hunter, Consultant in Paediatric Cardiology." 14 Firstly is that accurate? It was prepared by you? 15 A. It was prepared by me. Unfortunately I have been 16 heavily involved with another lengthy Inquiry, not as 17 lengthy as this one, but in London, and I followed that 18 up by going on a, I thought, well deserved holiday for 19 a week. Before I did, the week before I intended to do 20 this, my Secretary took ill, so I had to leave it for 21 her. She sent it in my absence, so that is correct. 22 Q. It was prepared by you but not signed by you at that 23 stage? 24 A. That is right. 25 Q. Are the contents, however, ones that you are happy to 0114 1 adopt as your evidence? 2 A. Yes, I have one or two minor spelling mistakes, but 3 apart from that, the general tenor was what I wanted to 4 say. 5 Q. So the gist of the evidence, if not the spelling, has 6 been accurate and true to the best of your knowledge and 7 belief? 8 A. Yes. 9 Q. You were invited by Mr Wisheart to form part of a team 10 of two with Professor de Leval to investigate paediatric 11 cardiac surgery in January 1995? 12 A. That is correct. 13 Q. You did not, however, come to Bristol as, as it were, 14 a complete novice, because you had had some involvement 15 with an earlier inspection at the hospital; is that 16 correct? 17 A. Yes. Perhaps I should explain that I am Chairman of the 18 Specialist Advisory Committee of the Joint Committee on 19 Higher Medical Training in Paediatric Cardiology, and as 20 such I carried out a follow-up visit and as I recall, it 21 was about 1989. It was to look at the training of 22 junior cardiologists. 23 Q. If we look at WIT 32/259, there is then a report of 24 a visit in fact on 19th November. We can turn over, 25 please, to the last page, which I think is some six 0115 1 pages on. If we perhaps go through it one page at 2 a time, please -- perhaps I can shortcut this by asking 3 you, Dr Hunter: is this the visit you can recollect? 4 A. No. I had nothing to do with this. 5 Q. If I look at -- 6 A. At least, I do not think I had anything to do with it. 7 Q. If I look at BCS 1/89, there is there an article on the 8 Eighth Survey of Staffing in Cardiology in 1992 and your 9 name is there amongst the authors. Is that part of the 10 same process or not? 11 A. No, that is a continuing manpower survey which is 12 carried out by the British Cardiac Society and to which 13 I contributed over the years. It was mainly run by 14 Professor Douglas Chamberlain, the first author. It is 15 to look at the number of cardiologists in the United 16 Kingdom and Northern Ireland and see whether there 17 should be more or less, and are we keeping up with 18 requirements from the staffing point of view. 19 Q. Taking you back to the visit in 1989, it was to do with 20 the staffing of cardiologists -- 21 A. The training. 22 Q. The training, I am so sorry. Did you make any 23 investigations into paediatric cardiology specifically? 24 A. Yes. 25 Q. What were the impressions that you formed of the 0116 1 adequacy of training? Were they such as to raise any 2 concerns with you at that time? 3 A. Well, they had been at a previous visit. As I said, 4 this was a follow-up visit. There had been a previous 5 visit about a year before by a Dr Shinebourne from the 6 Brompton Hospital, and he had decided not to give full 7 approval because of the problems which he considered in 8 the split site geography: that it was difficult, he 9 felt, to maintain a good level of supervision of the 10 junior staff between the two sites. 11 The people at the Children's Hospital then asked 12 the JCHMT if they could have a follow-up visit, because 13 they had by then plans to first of all move more on to 14 the children's site, but also that they had plans in the 15 long term to join the two sites together. I therefore 16 made the follow-up appointment. I personally did not 17 feel that the two-site geography invalidated the 18 training process. I have other views about the 19 management of patients, but it did not invalidate the 20 training process, and I said so, as a result of which, 21 the senior registrar post in paediatric cardiology was 22 accredited following my visit. 23 Q. Did you make any enquiries into the perceptions of 24 adequacy of paediatric cardiac surgery at the time? 25 A. Not as such. I was aware of the fact that it was going 0117 1 on. I was aware of the fact that it was a designated 2 supra-regional centre, but I did not, except in passing, 3 talk -- I talked to the surgeons because that is one of 4 the things we have to do. I talked to the surgeons to 5 make sure they can have their input into the training of 6 young cardiologists, which is very important. If I was 7 shown information about the surgical results at that 8 stage, I have no memory of it. 9 Q. In particular, then, nothing in your memory suggests 10 that any concerns were raised or triggered with you 11 about that aspect of the service? 12 A. Not from that visit. 13 Q. If we look at RCSE 2 -- 14 THE CHAIRMAN: May I interrupt just a moment for 15 clarification in my own mind? You said you did not 16 think that the split site invalidated training, but you 17 had other views about the management of patients. 18 How are those two propositions entirely severable? 19 A. I did not think, for instance, that the distance between 20 the Children's Hospital and the Royal Infirmary was such 21 that it would invalidate a young doctor in training 22 going from one hospital to the other to receive tuition 23 and training and so on and so forth. I did think, 24 however, subsequently, that there is a disadvantage 25 I think in having a two-site hospital, or system of care 0118 1 so far as the patients are concerned. I am not sure 2 I can take it further than that. You do not feel happy 3 with that response? 4 THE CHAIRMAN: We will move on. 5 MISS GREY: If we look, please, at RCSE 2/146, we see there, 6 if we scroll down, please, a letter asking Dr Hamilton 7 to set up a review of the supra-regional services in 8 paediatric cardiac surgery, a Working Party? 9 A. That is right. 10 Q. Which suggests that you might be part, or at least able 11 to attend a meeting and part of that review? 12 A. Yes. 13 Q. Is that a recollection that you can support? 14 A. Yes. 15 Q. Did you form part of the review, therefore? 16 A. No, I attended one meeting. It was a meeting held in 17 Sir Terence English's office at the Royal College of 18 Surgeons, and I do not think Keith Ross was there. He 19 may have been there for a period, but not for the whole 20 meeting. I was asked to come along to represent the 21 British Cardiac Society as one of the senior paediatric 22 cardiologists to talk about the matters we were 23 discussing. 24 Q. Was that after the report that we can see at RCSE 2/165 25 was produced? 0119 1 A. I think that is right. 2 Q. That suggests that you formed part of a Working Party? 3 A. Well, I attended one meeting, and that was the meeting 4 I have just described. I did not attend other meetings. 5 Q. It describes a meeting being held on Tuesday, 18th 6 February, in May; were you present at those? 7 A. I cannot remember the date that I was present, but I was 8 present, I know, at one meeting and one meeting only 9 with those people, with Terence English and I think 10 momentarily Keith Ross. 11 Q. So what took place at that meeting, then? 12 A. The discussion was about regulation, deregulation, of 13 supra-regional funding for infant cardiac surgery. 14 I think perhaps one of the reasons why I was asked to 15 give an opinion was that I had been somewhat critical of 16 the fact that when supra-regional funding was initiated 17 for paediatric cardiac surgery, it was for neonatal and 18 infant cardiac surgery, and I had felt all along, and 19 said at meetings, really it needed to be for the whole 20 of paediatric cardiac surgery and to have it only for 21 the small babies was not very logical. I think perhaps 22 when I said that, they decided I sounded like a chap who 23 had some interest in it. But this meeting was to look 24 at the supra-regional designation of various centres and 25 I am sure somebody has told you about how the 0120 1 supra-regional funding works before. 2 Q. Indeed, yes, we have heard evidence on that. 3 Was this report we see here something that was 4 tabled at the meeting, or available for discussion? 5 A. Not that I recall, so I think it must have been early on 6 in the year. I do not think I had seen the report at 7 that stage. 8 What I do remember is a very worried Terence 9 English -- I remember that the meeting that I was called 10 to was done on a sort of ad hoc basis, where you were 11 rung up and asked "Could you come next week, we have 12 a problem" and the problem I think was the initial 13 report in Private Eye about Bristol paediatric cardiac 14 surgery. That is my recollection of it. 15 He wanted to know what should be done about it, 16 whether this should be taken further and whether 17 deregulation or removal of designation should occur. 18 There were also discussions, I know, during the 19 afternoon -- I think it was just an afternoon meeting -- 20 about other centres which were under-performing in the 21 sense of low numbers. I think the general decision was 22 that there was no decision was made on that afternoon 23 that I was aware of, and as I say, that is the last time 24 I had an input into it, because it really was a surgical 25 matter. 0121 1 Q. Did you have any data available to you about the results 2 at Bristol if Private Eye had sparked in discussion or 3 adverse or comment on their results? 4 A. Not validated data on paper. We had the numbers, 5 because in those days, all that was collected year by 6 year to carry on the supra-regional funding was the 7 numbers. That is what we were asked for in various 8 centres. So we had just the numbers, which were quite 9 small in Bristol at that time, and I think the other 10 question -- we had no results, no. "How good was the 11 surgeon", that was not included. There was a suggestion 12 from Terence English that he had information that the 13 surgery here was below standard, taken as a whole 14 throughout the country, but it was not in my presence 15 backed up by any figures or data that I am aware of. 16 Q. If we went through further this document here and turned 17 in particular to page 169, we should see there a table 18 giving comparative data on a number of centres, 19 including of course Bristol, from 1988 to 1991? 20 A. Where is this from? 21 Q. This is from the report we have just seen. As you see, 22 it is dated June 1992. Do you recollect that being 23 tabled or discussed? 24 A. I never saw that at that time. 25 Q. Are you able to help us to date this meeting any 0122 1 further, Dr Hunter, because we see there that this table 2 is dated 23.6.92 and the series of Private Eye articles 3 that were coming out were, I think, in May and July of 4 1992. In particular if we can look at SLD 2/3, please, 5 we see there an article dated 8th May 1992, where, if 6 you scroll down the first paragraph, you can see there 7 criticism of the Bristol mortality rate? 8 A. Yes. 9 Q. If we also turn up, please, SLD 2/5, again the date is 10 scrawled across the top, if we can look at that first, 11 please, 3/7/92, and if we scroll down, please, you can 12 see that towards the end of the first column there is 13 there a discussion of the switch programme in Bristol. 14 So we have an article dated May 1992 and a table 15 dated June and a further article in July. Does that 16 help you to locate the date of this meeting? 17 A. All I can say is that I recall it certainly must have 18 been after the Private Eye article, because that was 19 discussed at the meeting that I attended. 20 Q. Can you help us any further as to the nature of 21 Sir Terence English's concerns and the information upon 22 which they were based? 23 A. He said that the first thing he had heard about it was 24 when this had been brought to his attention from Private 25 Eye, but he also had some information I think from other 0123 1 surgeons, and it may have been from David Hamilton 2 himself, who was a Professor of Cardiac Surgery in 3 Edinburgh at that stage, I think, and must have sat on 4 the supra-regional committee. So I think he was in 5 possession of information. So I think that is where 6 Terence English got it from. 7 Q. In any event, you say that the only data available for 8 that meeting was data on throughput rather than on 9 outcomes? 10 A. As I recall, what we discussed was whether or not the 11 smaller under-performing centres, of which Bristol was 12 one, and that was the purpose of the meeting, should be 13 de-designated. There were two other centres wanting 14 again at that time to come on to it, one was Leicester 15 and the other was Oxford. They were going to take the 16 numbers over 10 centres and the supra-regional funding 17 would cease to exist over 10. 18 Q. I asked you a question which I did not in fact follow up 19 to an answer. Do the series of articles and indeed the 20 data in the table help you to date the meeting any 21 further? 22 A. The meeting must have been after the first Private Eye, 23 I think, because it was certainly discussed. I could 24 not date it any closer than that. 25 Q. If we look at RCSE 2/188, this is a letter to 0124 1 Sir Terence English dated 15th July, and if we scroll 2 down, you will see that it is from Dr John Zorab. His 3 title again appears at the top of the letter, if we 4 scroll up again once more, please, the Medical Director 5 and consultant anaesthetist at Frenchay Hospital. He, 6 too, is raising concerns about performance at Bristol. 7 Was there any mention of this letter made at the 8 meeting? 9 A. Not that I recall -- when I say not that I recall, I do 10 not recognise the name "Zorab". I cannot honestly 11 remember too much detail about the meeting. 12 Q. If there were concerns being expressed, how did the 13 meeting resolve them, or resolve to take the matter 14 further? 15 A. To my knowledge, they did not come to -- the meeting 16 I attended did not have a decision at the end. I think 17 David Hamilton was going to go away and talk to, 18 I assume, the Cardiothoracic Surgical Society and 19 discuss it further. I was there really as an observer, 20 to be quite honest. I put my two pennyworth in and said 21 I had had a visit to Bristol on another matter, as you 22 have heard; I talked in general about the future of how 23 we were going to go with the supra-regional funding, but 24 as far as I recall, there was no final decision. Nobody 25 said Bristol must be investigated or they must be 0125 1 deregulated or anything like that. I think it was taken 2 away, as they say in Scotland, ad avizandum, if that is 3 a correct legal term. 4 Q. Which for those of us at the moment would mean what? 5 A. Take it to further discussion and investigation, 6 I think. I am sorry about that. 7 Q. Dr Hunter, the evidence you have given today may give 8 rise to further questions from those in particular who 9 may wish to comment upon it, so it may be that we will 10 revert back to it with you, but for the moment, if I may 11 pass back to WIT 2322, please -- 12 THE CHAIRMAN: May I ask one question, again for 13 clarification? You referred, Dr Hunter, to small and 14 under-performing centres such as Bristol. Correct me if 15 I am wrong, but I take it you mean by under-performing 16 in terms of numbers; or am I wrong? 17 A. No, you are quite correct, because the point I was 18 making was that the supra-regional funding was based not 19 on the outcomes, I think Mr de Leval said this earlier, 20 but on actual numbers. 21 THE CHAIRMAN: Thank you. 22 MISS GREY: If we could go back to WIT 322/1, returning to 23 your statement, then, you set out there the aims of the 24 visit at the top paragraph, which we now see. How were 25 you advised on the aims of that visit? 0126 1 A. I think in a letter from Mr Wisheart, in writing to 2 come, but I think also, more probably, the aims were 3 given to me over the telephone by Marc de Leval. 4 Q. We can see at JDW 3/312, your letter of appointment. Is 5 that the letter you were referring to? 6 A. Yes, it is. 7 Q. And it may perhaps be a fair comment to say that there 8 is not an enormous amount of guidance given on the terms 9 of reference in that letter. Can you remember being 10 told much more by Professor de Leval? 11 A. I think we discussed basically if we were going to be 12 able to do anything significant in the time which we 13 were being given, and he has alluded to it earlier. 14 I mean, it is a continuing problem that I have just been 15 through in another centre recently, where you are asked 16 for very important decisions and to do very detailed 17 examination of facts in a very short time. I think the 18 sort of gun that was pointed at our heads was that it 19 was critical and crucial to know whether the surgery 20 should continue, or whether the decision had to be made 21 that it should be referred elsewhere before Mr Pawade 22 arrived. 23 I do not think we had much more in the way of 24 guidance given to us than that. 25 Q. Was there any discussion either before you arrived or 0127 1 when you arrived of the role of the Department of Health 2 in deciding or advising the Trust on whether or not 3 surgery could be allowed to continue? 4 A. Well, the surgery, the neonatal surgery, had in fact 5 been stopped by Dr Doyle's edict. That had happened 6 before we arrived. We were supposed to say what should 7 happen from there on. I think that was the prime thing 8 they wanted to know, what should they do from there on? 9 What should be their modus operandi from there until 10 such time as the new surgeon arrived, which we dealt 11 with at the end of our report, and which Mr Nix agreed 12 to in his protocols. 13 Q. The first meeting, when you arrived at the UBHT, was 14 with Dr Roylance. Can you recollect what he told you 15 about your brief, as it were, at that stage? 16 A. As I recall, he was very general in saying he wanted us 17 to have free access to whatever information we wished; 18 that he hoped everybody in the department would be 19 completely co-operative and saw no reason why that 20 should not happen; and we were to ask for whatever 21 further information we required. It was just a very 22 general "Welcome to Bristol, we are grateful to you for 23 coming and seeing whatever you want to, we will try and 24 do it for you". 25 Q. We can perhaps help by turning back to WIT 319/13, 0128 1 please. 2 We have heard earlier from Professor de Leval that 3 these are your notes, prepared and faxed back to him to 4 assist him. 5 A. That is right. 6 Q. Dr Roylance offered carte-blanche; you have just told us 7 that. Stated his concerns about the service. How were 8 they phrased? 9 A. I think he emphasised a great deal of division within 10 the service and a lack of working together in 11 co-operation, which we discovered. I think those were 12 his major concerns. 13 Q. What about his concerns about professional loyalty in 14 some members of staff involved in the dispute? 15 A. I am not sure whether he talked to us on that occasion. 16 I cannot remember. I know that this question about 17 professional loyalty and members of staff was raised, 18 and let us not beat about the bush, it was raised 19 I think with regards to Dr Bolsin, but I am not sure 20 whether it was Dr Roylance. I cannot honestly remember 21 whether it was he who raised that, or whether it was 22 somebody else during our visit. 23 Q. If it was somebody else, are you able to help us on who 24 that might have been? 25 A. No. I cannot honestly remember. Certainly, the 0129 1 impression was that there was some concern about 2 professional loyalty. 3 Q. Because Dr Bolsin may say that the impression he got, 4 having met with you at a later stage, was that you might 5 have been given information by Dr Roylance which would 6 have set you against Dr Bolsin, or in some way 7 influenced or biased your judgment on the events that 8 Dr Bolsin was recounting to you? 9 A. He may well say that and he may well feel that, but 10 I did not feel that that was the case. I think we tried 11 to be as impartial and as open as we could be with 12 everybody that we spoke to. Dr Bolsin was amongst 13 them. He had a long session with us, and he presented 14 us with his surgical data. 15 Q. But the point that he is making is not solely in 16 relation to you, Dr Hunter; he is suggesting that the 17 presentation by Dr Roylance in particular may have been 18 less than impartial. 19 Is that an impression that you took away from the 20 meeting? 21 A. No, certainly not. 22 Q. If we go back to your statement, please, WIT 322/1, at 23 the bottom you set out the programme under the heading 24 "Programme of the visit" an account of the services, 25 and you say at the bottom that "since Mr Dhasmana 0130 1 arrived in 1985, the latter [Mr Dhasmana] bore the 2 lion's share of the paediatric surgical practice." 3 Mr Wisheart has provided us with comments in which 4 he says that firstly Mr Dhasmana took up his consultant 5 appointment in January 1986. You prepared this 6 statement from a mixture of memory and notes; is that 7 correct? 8 A. Notes, yes. 9 Q. So presumably you accept Mr Wisheart's -- 10 A. Absolutely, yes. 11 Q. He continues: 12 "We worked closely together and the paediatric 13 surgical practice was shared very evenly between us. 14 The chief difference was that from the latter part of 15 the 1989 onwards..." I am sorry, only Mr Dhasmana 16 carried out the arterial switch operation. 17 Is it right to say that notwithstanding what 18 Mr Wisheart says in his comments now, the impression 19 that you and Professor de Leval gained contemporaneously 20 was that Mr Dhasmana was carrying out the lion's share 21 of the paediatric practice? 22 A. I have to say, that is the impression we had at the 23 time. I still think that is the impression we were 24 given. 25 Q. We can confirm it if necessary from the report, but it 0131 1 is right, I think, that both versions of the report make 2 that point, with the second version qualifying it merely 3 by the statement that Mr Wisheart has done less since he 4 became Medical Director? 5 A. Yes. If I may, one of the things that I remember 6 looking at was, in the comparison of the AV septal 7 defect surgery we said in the first version of the 8 report one surgeon had operated on seven under 1 year 9 and six deaths, whereas the other had done 80 with only 10 two. That is more than twice. I think that is evidence 11 that we were aware of the fact that Mr Dhasmana was 12 doing if not the lion's share -- I do not know how you 13 define the "lion's share", but more than Mr Wisheart. 14 Q. Just then you were looking at papers that you have with 15 you. I think it is right that you have in your 16 possession the papers that were given to you by the 17 various parties concerned at the time of your visit? 18 A. Yes, some surgical results, as I recall, the ones 19 I showed to you earlier. 20 Q. And as you have just indicated, you were able to provide 21 us with those at lunchtime. They will, therefore, be 22 scanned in and made available more generally within the 23 Inquiry. 24 Sir, the position we have at the moment is that 25 the data in the form provided to Dr Hunter raises issues 0132 1 of patient confidentiality and so it will, if it is 2 acceptable, be redacted and made available after a short 3 break -- in other words, not today -- to enable us to 4 take that difficulty into account and again, if 5 necessary, if there are any further issues raised by it 6 which any participant wishes to raise, they will have to 7 be dealt with on the back of that particular difficulty. 8 THE CHAIRMAN: Yes, it is important that everybody has 9 access to those papers so that they can help the Inquiry 10 if they have any questions. But equally, we have to 11 safeguard matters such as confidence. I hope therefore 12 that others will be content to wait until tomorrow on 13 your undertaking that they will be made available. 14 MISS GREY: We can I think do a little better than that by 15 running through the headings of what was presented to 16 you. We have seen I think already -- this is at UBHT 17 61/80 -- some data provided by Dr Bolsin. I think you 18 can confirm that was part of what was presented. If we 19 turn over the page at page 81, that is also familiar to 20 you, is it? 21 A. Yes. 22 Q. The breakdown of various results. 23 A. Yes. 24 Q. Equally well, if we turn, please, to GMC 16/38, that, 25 too, would be part and parcel of the material that was 0133 1 provided to you by Dr Bolsin; is that correct? 2 A. Can I just have a look to check that? (Pause). Yes, 3 I can confirm that. 4 Q. In addition to that, would it be right that you were 5 provided with a table described as "The results of 6 Bristol paediatric cardiac surgery, open, January 1992 7 to January 1995 inclusive", with a heading "Under 8 1 year" which broke the results down according to 9 various diagnoses? 10 A. Yes. 11 Q. Another table similar but marked "Miscellaneous" with 12 a breakdown of results for both under and over 1 year? 13 A. Correct. 14 Q. Was that data provided to you by the surgeons or by 15 Dr Bolsin? 16 A. As I recall, it was provided by the surgeons, but I do 17 not have a note on that and I have to say, when writing 18 my report I went through my file and found this at the 19 bottom of the file, in a separate folder with my name on 20 it, and I thought it was given to me by the surgeons and 21 I did not think it was given to me by Dr Bolsin. 22 Q. There is a table entitled "Bristol paediatric cardiac 23 surgery, closed surgery under 1 year of age, 1990 to 24 1994, March"? 25 A. Yes. 0134 1 Q. Is that something that came from you, from Dr Bolsin or 2 from the surgeons? 3 A. I think that came from the surgeons. 4 Q. And the same but entitled "Closed surgery over 1 year": 5 would the same apply? 6 A. Yes. 7 Q. There is then a table entitled "Anatomical correction, 8 non-neonatal switches" dealing with the details of some 9 25 operations in considerable detail. 10 A. Yes. 11 Q. Did that come from the surgeons? 12 A. That is my recollection, but I cannot be 100 per cent 13 certain. I certainly came away from the meeting with 14 them, I know that. 15 Q. Can I put it like this: you discussed with the surgeons 16 the results of the switch operation. Was it based upon 17 a table such as this? 18 A. I think so, but I cannot 100 per cent recall it. 19 Q. Because there is another similar table, is there not, 20 which deals specifically with the neonatal switches? 21 A. Yes. 22 Q. And relates to some 13 patients? 23 A. Yes. I think the information which is included on this 24 is very detailed, including postmortem detail as well. 25 I am sure we saw these and discussed them with the 0135 1 surgeons at the time of the visit. 2 Some of our information that Mr de Leval mentioned 3 to you earlier about the high risk cases, I am sure some 4 of that information came from these tables. 5 Q. The calendar of events has already been referred to as 6 coming from Dr Bolsin? 7 A. Correct. 8 Q. There is also a report in narrative form entitled "UBHT 9 paediatric cardiology and cardiac surgical services", 10 which sets out a description of the services and the 11 staff involved. 12 A. That is correct. 13 Q. Can you remember who provided that to you? 14 A. I think that was given to us when we arrived. It is 15 a fairly general one. It is the sort of prospectus you 16 might give to anybody coming to see your department. 17 I think I was given a similar one, not that one, on my 18 previous visit, describing what went on. 19 Q. Is that a reference to the visit you were conducting 20 when you -- 21 A. The training visit from the College, yes. 22 Q. I have here also two further tables in the form that 23 I described at the beginning, "Bristol paediatric 24 cardiac surgery, open, January 1992 to 1995". 25 A. Yes. 0136 1 Q. Again, breaking the results down into diagnosis. And 2 finally, a table entitled "Cumulative mortality". 3 Where did that come from? 4 A. I am ashamed to say I cannot remember seeing it. This 5 is the one that was in this folder. I cannot tell you 6 for sure where that came from. 7 THE CHAIRMAN: Miss Grey, I am a shade getting lost with 8 the various documents, the cross-references and so on. 9 Can you tell me what you have been doing in the last 10 10 minutes? I take it you have been establishing that 11 certain documents exist and they describe something 12 without being able to descend to the content and what 13 the provenance of those documents was? 14 MISS GREY: Precisely. As soon as those documents can be 15 redacted to the extent they need to be, and I presume it 16 is relating only to the arterial switch data, we will be 17 able to put links to the documents and be able to know 18 where they came from. 19 THE CHAIRMAN: We can join up the dots in the current 20 transcript. 21 MISS GREY: Yes. I am sorry it has been done in this clumsy 22 form in this way. 23 Can I ask you one final question, Dr Hunter? 24 I have also in my possession a table entitled "Table 1, 25 Bristol paediatric cardiology and cardiac surgery, 1989 0137 1 to 1990 statistics". Where did that come from? 2 A. Will you bear with me while I find that one? The title 3 is -- 4 Q. "Bristol paediatric cardiology and cardiac surgery, 5 table 1, 1989 to 1990 statistics". 6 A. Will you give me the date? 7 Q. 1989 to 1990. There is a clip of papers there. 8 A. That is right, I have that. 9 Q. Where did they come from? 10 A. I am assuming that I was given this at the visit as 11 well, but who exactly provided them I am not sure. This 12 is the one with cardiac catheterisations and 13 echocardiography and the like, on the subsequent pages? 14 Q. Yes. Is there any possibility you might have had it in 15 your possession before the visit? 16 A. I do not think so because my files were kept entirely 17 separate. But -- I do not know for sure who gave it to 18 me. I thought it came on this occasion. 19 Q. If we can go back to the statement that you gave, 20 please, WIT 322/2, you describe there the provision of 21 echocardiography. I am looking at the second 22 paragraph down. It was available both routinely and 23 acutely on both sites; at the Bristol Royal Infirmary it 24 was done under the care of the radiologists. Does that 25 make any difference? 0138 1 A. As it happens in Bristol, no, because they were very 2 fine radiologists who are very good at 3 echocardiography. In other places it might have. It is 4 very vital at that echocardiography is available in the 5 post-operative care of children because it can make 6 diagnoses very rapidly and if you run a centre for 7 infant cardiac surgery, you must have 24 hour 8 echocardiography. 9 Q. You give the impression in your list of meetings that 10 you met each of these people in turn and separately. In 11 fact, some of these meetings were joint? 12 A. Correct. 13 Q. Was there any problem caused by that? 14 A. No. We met Dr Roylance by himself. I think we were 15 then joined by Mr Wisheart. We then met Mr Wisheart and 16 Mr Dhasmana. We saw the paediatric cardiologists 17 together. We did not see Dr Joffe who was on holiday in 18 South Africa. We saw Dr Bolsin by himself, Dr Monk by 19 himself, Sister Thomas by herself, Professor Angelini by 20 himself, and I think Dr Hughes by himself. 21 Q. But in particular, the cardiologist was seen at the same 22 time as the cardiac surgeons; was that appropriate? 23 A. No. I think we saw them separately. I think we saw -- 24 we saw everybody together at the end of the day, but 25 I think we saw them separately, but you may have 0139 1 information to the contrary. That is my recollection. 2 Q. I think the suggestion made in the programme of 3 events -- we will look, please, at UBHT 61/355 -- 4 A. This is the one that was presented to us when we 5 arrived, yes. 6 Q. -- was that Mr Wisheart and Mr Dhasmana would be joined 7 by -- 8 A. If that is the way it was, that is the way it was. 9 I did not remember it. I know we had a long chat with 10 Dr Martin and Dr Hayes. In fact I think we met 11 Dr Martin and Dr Hayes the night before as well, but 12 anyway, it looks as if we did meet them. I certainly 13 remember meeting Janardan Dhasmana and James Wisheart 14 together, and Dr Bolsin and Dr Monk separately. 15 Q. You are saying you were down there on the preceding 16 night? 17 A. I think I came down by train the night before, so far as 18 I remember. 19 Q. On your own or with Professor de Leval? 20 A. I cannot remember. I think I was on my own, but I am 21 not sure. I cannot honestly remember. I stayed 22 overnight, anyway. 23 Q. Do you recollect who if anyone you met from the UBHT 24 team then? 25 A. I thought I met Dr Martin and Dr Hayes. 0140 1 Q. And if you did, did they have anything to say to you at 2 this stage about the services that you were 3 investigating? 4 A. I cannot recall us getting into great detail about it. 5 As I remember, it was a social evening. I think we went 6 for a meal somewhere and had a chat. I do not think we 7 got into any great detail because we realised we were 8 going to be talking about it on the following day at 9 great length. 10 Q. Because, if we look at your series of notes, and we 11 started the sequence at 319/13, we would not find any 12 discussion or account of the discussion with the 13 cardiologists. 14 Are you able to help us, are you able to recollect 15 any material information provided by them? 16 A. I seem to remember they indicated a general support for 17 the attempts by Mr Dhasmana and concern that he was 18 having problems with the switch. That would be very 19 natural; they worked very closely together. I think 20 they also indicated concerns over the split site and the 21 need to reconsider where the intensive care was carried 22 out, which I think is very reasonable. 23 Indeed, as I remember, Dr Martin described to us 24 what the potential changes were with the new ITU in the 25 Children's Hospital, and he I think it was who 0141 1 introduced the possibility of eventually the two 2 hospitals going on to one site. 3 I think they were generally supportive of their 4 colleagues and worried about the effect of the surgery, 5 obviously, and where they should go from there. 6 Q. If we go back, please, to WIT 322/3, you set out the 7 background to the current problem. In particular, at 8 1992, you say the media became involved when an article 9 highlighting problems with surgery in Bristol were 10 published in Private Eye. 11 Was this a matter which was discussed on your 12 visit? 13 A. Not as I recall, no. 14 Q. So where does that comment come from: your own 15 involvement in the matter at an earlier stage? 16 A. It is my own involvement, and also Dr Bolsin, I think, 17 mentions it in one of his comments. 18 Dr Roylance mentioned it. I see in my notes he 19 talked about this present problem. 20 Q. When you say you see in your notes, is that a reference 21 to WIT 319/13, please? Do we have those notes? 22 A. Yes. He says, in answer to a direct question, he felt 23 this problem had nothing to do with the Private Eye 24 publication several years ago. 25 Well, I knew about it, for obvious reasons, as you 0142 1 have heard. 2 Q. Turning back to WIT 322/4, please, and to your account 3 of the findings and perceptions collected during the 4 visit. Describing the mixed results according to you of 5 the auditing of surgical results, when you say "on the 6 other hand the manner in which it was carried out caused 7 great animosity and division in the department and this 8 was probably counter-productive", what is that 9 a reference to? 10 A. It is a reference to several things. It is a reference 11 to the lack of communication which went on throughout 12 the department which we are aware of; it is a reference 13 to Dr Bolsin's collecting separately information. And 14 it is a reference to the fact that, as we have heard 15 earlier, the surgical results collected by the surgeons, 16 we were under the impression had not until just before 17 the meeting been made available to other members of the 18 department. There was great animosity felt by a number 19 of people. They felt they had not been fully informed 20 about what had been going on. We had this from several 21 people. 22 Q. Can you name them? 23 A. Yes. In fact I am sure I put it in my -- 24 Q. Dr Hunter, I think it would be useful if you could 25 confine yourself to answering the questions from your 0143 1 recollection, rather than seeking documentary 2 confirmation of where you may have written it already. 3 A. Sure. 4 Q. If you can tell us, please, who you can recollect 5 expressing that animosity? 6 A. One of the anaesthetists I think was expressing that 7 animosity. That is why I was looking up who it was. 8 I will leave you to it. 9 Q. Anyone else? 10 A. I also felt, like Marc de Leval, that Professor Angelini 11 was -- his attitude, I thought, would not have made the 12 department a happier place to work in, and would not 13 have been conducive to healing and improving matters. 14 He was very worked up about it all. As Marc said, it 15 may well have been that he was just very concerned about 16 it, but we both commented afterwards that he was very 17 angry about the whole business. 18 Q. There were two anaesthetists seen. Firstly, if we look 19 at 319/16, please, here is your account of seeing 20 Dr Pryn. 21 A. Yes. That is the one I remembered, yes. 22 Q. Is "animosity" an accurate term to describe his 23 attitude? 24 A. Unhappiness, animosity, yes, he felt unhappy with the 25 situation. 0144 1 Q. If we turn over the page to 17, please, we see the 2 account of the discussion with Dr Monk at the bottom, 3 please. He, too, expressed concern about unsatisfactory 4 access to figures? 5 A. He did. 6 Q. How would you characterise that concern? 7 A. We felt that Dr Monk had his finger on what was going 8 on, as I have said. He was very lucid. He listed all 9 the problems, he was aware of them, he was unhappy about 10 them. He knew that the results of surgery were less 11 than adequate, as he said, and he felt unhappy about the 12 unsatisfactory access to figures until quite recently. 13 It is there. 14 Q. If we go back then to your witness statement at page 4, 15 please, when you said at paragraph 1 that the audit was 16 probably "counter-productive", is that an overall 17 judgment on the audit as a whole, or on the manner in 18 which it was carried out? 19 A. I have no doubt it was the manner in which it was 20 carried out. I would be the last person to suggest that 21 audit is not a good idea. Audit is an excellent idea 22 and is essential to any clinical department. But as 23 I have said at the beginning of that paragraph, the 24 auditing of surgical results did have mixed results. It 25 had the effect that it brought the problem to 0145 1 everybody's attention very dramatically, but it did not 2 make life easy for those who were trying to be 3 constructive thereafter, much as Marc said earlier. 4 Q. You have echoed in your witness statement the perception 5 that the surgeons were not sharing results with other 6 people within the department. We have just alluded to 7 it now. Can I ask you firstly, what was the norm for 8 the analysis and sharing of data in your own unit at the 9 time? 10 A. In 1995? 11 Q. Yes. 12 A. In 1995 we had instituted a monthly meeting which was 13 a monthly clinical audit at which the previous month's 14 mortality, morbidity, were presented. The cumulative 15 data for the earlier months of the year were added in. 16 Individual cases were highlighted and the information, 17 the clinical data, looked at. Decisions were therefore 18 implemented and recorded, so that is what our audit data 19 did. Then once a year, and I think this started in 1992 20 or 1993, at the end of each year we have cumulative 21 results which are then compared with the previous year. 22 Q. I think you were present in the Inquiry chamber when it 23 was put to Professor de Leval that in fact extensive 24 data analysis or publication had been made available by 25 the cardiac surgeons and in particular, Mr Wisheart 0146 1 draws attention to annual statistical summaries being 2 prepared from 1994 onwards to regular clinical 3 pathological conferences, to an audit programme in the 4 Children's Hospital called paediatric cardiological 5 audit, and also to cardiac surgical audit taking place 6 on roughly a monthly meeting basis, as well as a series 7 of ad hoc meetings. 8 Were the details of those meetings, if true and 9 accurate, brought to your attention during this visit? 10 A. I must say, I was not aware. If they are as extensive 11 as that, I was not aware of it. 12 Q. And again, are you able to assist the Inquiry on 13 resolving any conflict that there may be between the 14 various individuals concerned with the paediatric 15 cardiac surgery service as to the sharing of data that 16 did take place at the time? 17 A. I am afraid I can only comment on what I have recorded 18 from my notes at the time, and that was a number of 19 people saying to us that they had not been aware of the 20 surgical data until literally a few days before, or 21 shortly before. That was the impression I got. 22 Q. You go on at paragraph 2 to comment about the 23 involvement of a senior medical member of staff in the 24 Department of Health at an early stage being 25 inappropriate. Is that again based upon your 0147 1 understanding of the implications and importance of 2 professional self-regulation? 3 A. Absolutely. I know you have already been spoken to by 4 Dr Michael Godman, the President of the British 5 Paediatric Association, and one of the things he 6 mentioned to you -- I was part of the group that drew up 7 the report he presented -- is that that particular 8 organisation is fairly unique in that it covers 9 paediatric cardiologists, paediatric cardiac surgeons, 10 paediatric intensivists and anaesthetists, and so on and 11 so forth, and they are therefore a body, a specialist 12 body, representing this group. We are determined to 13 self-regulate ourselves in the future, and we feel that 14 on a regular basis, quinquennial or triennial or 15 whatever visits by a group representing this 16 organisation will be a matter not of choice but of 17 necessity and the intention is that we will therefore, 18 hopefully, as Marc de Leval earlier suggested, pick up 19 at an early stage if something was going amiss with 20 a particular unit, as well as providing a rather more 21 quick hitting alternative which could be activated if 22 something seriously went wrong very rapidly. 23 So "Yes", is the answer. 24 Q. If we turn over the page, please, to page 5, you say at 25 paragraph 4 that there were confusingly two sets of data 0148 1 given to the visitors during the meeting. 2 Mr Wisheart again comments on that, saying this: 3 "Professor de Leval and Dr Hunter invited the 4 surgeons to produce data, which they did in full." 5 Firstly, are you able to help the Inquiry as to 6 what requests, if any, were made in advance of your 7 visit? 8 A. I made no such requests. I think Marc, in speaking as 9 he said earlier, almost certainly -- I do not think he 10 wrote asking for results, but it would be a logical 11 thing if you were invited to come and do a review, you 12 would say, "By the way, we need all your surgical 13 results". 14 Q. He continues: 15 "Dr Bolsin was seen by the visitors and he 16 provided them with data that he prepared privately. 17 Neither the existence nor the substance of this data was 18 known to the surgeons. It was only at the final meeting 19 when all those who had given evidence gathered together 20 that the existence of this data gathered by Dr Bolsin 21 first became known to the surgeons." 22 Are you able to help us on what sharing of data 23 took place at that final meeting? 24 A. It was, as I remember, the data which Dr Bolsin has 25 produced. 0149 1 Q. But what form did the discussion take at that stage? 2 A. At the final meeting, which I have to say was carried 3 out in the late afternoon, and was in a bit of a rush 4 because I for one had -- both of us had to be away 5 briskly that evening, otherwise we were going to have to 6 spend another night in Bristol, I cannot honestly 7 remember exactly. We discussed with the various people 8 what our findings were. We said that we would be 9 producing a report. We felt it was only reasonable to 10 tell them that we had found some problems and what we 11 thought the problems were, but we thought it was also 12 reasonable to say that the things they had undertaken to 13 do, such as appointing a new surgeon, retraining 14 anaesthetists, switching the ITU, were all entirely just 15 as we would have recommended. 16 I cannot remember the details of this coming up at 17 that meeting. 18 Q. That is the data from Dr Bolsin? 19 A. Correct. 20 Q. You carry on to say at the end of that paragraph that 21 "some of the deaths undoubtedly occurred well beyond 22 the immediate operation with no clear surgical cause of 23 death." 24 If death took place outside the immediate surgical 25 period, do you believe that you managed to get to the 0150 1 bottom of the causes then of those types of death? 2 A. Not in any great depth or detail, as Mr de Leval 3 mentioned earlier. We have a list of the switches and 4 the high risk cases that died. Without actually pulling 5 the notes and looking at them in great detail, which 6 would take a lot of doing, we did not have the time to 7 do that. We can only surmise that because they were 8 very high risk abnormalities, the circumflex coronary 9 artery, the sinus and the intramural coronary, these are 10 things which are known and recognised to be high risk 11 cases. But we can only take the information that we got 12 on that day, which was as you mentioned on one of these 13 forms. 14 Q. If we turn over the page, please, you have reviewed the 15 data, their variability and the implications from them, 16 and then you go on to say that the mean national 17 mortality was arrived at using figures from two or three 18 units with better results and two or three units with 19 the same or worse results than Bristol. 20 What data were you referring to then, when you 21 spoke of "mean national mortality"? 22 A. The "mean national mortality" was what is provided by 23 the UK Cardiothoracic Surgical Register. I think, now 24 that I read that sentence, what I am in fact referring 25 to, and I may not have put it very clearly, is that the 0151 1 mean national mortality is an average, it is a mean, and 2 it is arrived at because some people have better results 3 or higher mortality and some people have lower 4 mortality, and I think what I am implying is that if the 5 Bristol results were worse than the mean, they probably 6 were one of several units that made the bottom half of 7 the equation because, you know, if you have a mean or an 8 average in a population, you have to have those below 9 the line and those above. 10 Q. I think we understand the concept of a mean, but the 11 point is that you are not able to say, surely, that two 12 or three units must have had the same or worse results 13 than Bristol? 14 A. I think in retrospect, on reflection, that is probably 15 a correct assessment. 16 Q. You say that there was no better database information to 17 compare with local results, but was there not 18 information available firstly from published papers and 19 secondly from discussion with colleagues that would give 20 you a fair idea of what was going on? 21 A. Discussion with colleagues is fine. I have done it 22 myself. You sit there and say "How many cases of 23 such-and-such have you seen recently? What have the 24 results been?" and the answers come back, "They are 25 excellent" and all the rest of it. We all use the 0152 1 retrospectoscope a little bit. You have to have the 2 validated data to compare if you are making a serious 3 comparison. The problem is that at that time, and 4 probably still to today, there is not a great deal of 5 validated data: by "validated", I mean validated down to 6 the actual autopsies carried out and scrutinised. 7 As far as the published results are concerned, 8 published results are usually published by people who 9 have a good result from a particular operation, 10 procedure or treatment or whatever. In that particular 11 period of time and in that particular situation they 12 have excellent results. To compare them with national 13 averages is, I think, inappropriate and would not be 14 allowed by statisticians. 15 Q. Going on to the conclusions in this statement, you say 16 in the second sentence: 17 "Those who initiated the auditing activities gave 18 the impression they were intent on policing the surgical 19 activities." 20 What did you mean by that? 21 A. Basically that they gave the impression that they were 22 watching the results because they had recognised that 23 there was a problem there. I am not saying you should 24 not watch the results, but the impression was very much 25 that they were more interested in looking at the 0153 1 surgical activities for bad results, if you like, or 2 picking up the bad results, rather than trying to get 3 together and working a solution out. Although I have to 4 say the Trust as a whole had worked a solution out by 5 the time we came to speak to them. 6 Q. You carry on to say that the figures presented by 7 Dr Bolsin were incomplete and fail to give a total view 8 of the problem. Dr Bolsin gave figures on certain 9 procedures. Would it not be justified to focus on 10 particular operations if they could be said to be either 11 sensitive indicators of a problem, or else operations 12 which should be stopped because the unit was 13 particularly bad at them? 14 A. As I understood it, the figures about the switches were 15 not in dispute. There is a case, I have to admit, for 16 using what are called "benchmark lesions". That is what 17 the Cardiac Surgical Society are doing now. They have 18 identified benchmark lesions. Transposition of the 19 switch is one of them, AV septal defects is another, and 20 so on and so forth, and using them to look at individual 21 surgeons' performance and national performances and 22 regional performances. 23 It was my impression, without going over it again 24 and referring to all the papers, that Dr Bolsin's 25 figures did not exactly tally with the results presented 0154 1 by the surgeons. I thought at the time our view was 2 that they failed to give a complete view of the problem. 3 Q. But Dr Bolsin, in particular, took an operation on 4 single ventricles and took the results on that because 5 he knew that Bristol had a good record in that 6 operation? 7 A. You have the advantage on me. I have not looked at 8 that. 9 Q. You can look at UBHT 61, GMC 16/8, please. This was the 10 data already identified by Professor de Leval earlier 11 this morning. I think Dr Bolsin's evidence may be that 12 he picked this procedure so as to balance events by 13 picking out one at which Bristol had a good record, or 14 a proper record. 15 A. I honestly do not know how valid it is to compare 16 Bristol with the rest of the UK for these operations. 17 First of all, it does not say what the operations are; 18 it says the top one is single ventricle under 1 year and 19 the second is single ventricle Fontan. There could be 20 all sorts of variations of Fontans. You would have to 21 specify them. It is one of the most complex systems of 22 abnormalities, the single ventricle. I do not think 23 that is terribly meaningful, to be quite honest. 24 I could not comment on it. 25 Q. Could we go back, please, to WIT 322/6. 0155 1 You also comment that there was in general a lack 2 of understanding of the problems of paediatric cardiac 3 surgery. 4 What did you mean by that? 5 A. The fact they were still continuing to look after 6 children on an adult ITU shows manifestly they do not 7 understand the problems of paediatric cardiac surgery 8 and how children should be handled. That is something 9 which people used to do but have moved away from very 10 dramatically because you just have to be an expert at 11 handling smaller children post-operatively. The 12 anaesthetists have to almost spend their whole time 13 doing small children. If you do not do it often, you 14 are not good at it and the results show. I think that 15 is what I was referring to. 16 I think possibly also that nobody had, up until 17 the time the problems came along, even thought that 18 there was anything wrong in having children operated on 19 in an adult ITU. 20 Q. But the way it is phrased in that paragraph implies that 21 it was the anaesthetists, or those rather who initiated 22 the audit activities, who lacked understanding of the 23 problems of paediatric cardiac surgery. 24 Was that intended to be -- 25 A. It certainly was not intended. I certainly would not 0156 1 read that, and I certainly would not intend it. 2 Q. You go on to talk about a chain of command that was 3 hopelessly vague in the existing ITU unit. Firstly, 4 Dr Hunter, can I ask you what involvement, if any, did 5 you have in any changes that were made to the report 6 after the first version had been sent through to the 7 Trust? 8 A. I personally did not make any real changes. There were 9 some textural changes, "I would have said this rather 10 than that, and put it this way", which I put through to 11 Marc and he sent that off. 12 Q. That was the report that went in on the first? 13 A. The first one. He informed me by telephone that there 14 were other changes -- that other changes had been made, 15 and I was listening to you questioning him earlier, 16 because I could not remember offhand what had been 17 said. I knew that he felt that we had been somewhat 18 harsh in one or two things that were said, but that is 19 all I can remember. I remember at the time listening to 20 what he said and accepting his version, and agreeing 21 with it. 22 Q. I think it may help us if you can clarify a little 23 further: did you at any time discuss with him any 24 proposed changes to the report by, say, being sent 25 through a second revised version for your approval? 0157 1 A. I certainly got a second revised version, because I have 2 got it. I am sorry, I am assuming on the telephone 3 I approved it. I may in fact have a letter saying 4 "I think this is satisfactory", but I could find that 5 for you. 6 Q. I think that would be helpful, if you have further 7 papers in your possession, if you could do that after 8 today's evidence. 9 Did you yourself have any discussions with any of 10 the clinicians in Bristol, or any of the other figures 11 from within the Trust, as to whether or not the first 12 report required any revision? 13 A. No. 14 Q. So any communication was via Mr de Leval? 15 A. Yes. 16 Q. We have discussed already this morning, in particular, 17 the fact that the second version of the report removed 18 from it any adverse criticism of Mr Wisheart's AV canal 19 series, or any conclusions from that information. 20 Was that something you discussed with Mr de Leval? 21 A. I honestly cannot remember, but like Mr de Leval 22 I thought that had been kept in. It was surprising to 23 me when I sat there listening this morning that it was 24 not in the second one. I did not remember that. 25 I personally thought it was an important point. But 0158 1 that is in retrospect. 2 Q. Can you remember any discussion on how these particular 3 series should be treated in any revised report between 4 yourself and Mr de Leval? 5 A. As I recall, what happened was that the first report 6 came through and I wrote to him and said "I think that 7 is satisfactory; I have made no major changes", sent it 8 back to him. Then I think he telephoned me and said 9 that after discussion with I think Mr Nix, he felt that 10 it was necessary to make one or two changes to soften 11 some of the statements and I said, "Fine, just send me 12 the report" and he did send me a copy, the final of 13 which I have, the second one. 14 What I think I did was I wrote back saying, 15 "That's fine". 16 THE CHAIRMAN: Can I ask one question, again for my own 17 understanding? When you said you thought something had 18 been left in, given that it was not left in, who are you 19 saying took it out? 20 A. I am assuming that Mr de Leval felt that that was one of 21 the points where we had been over-strong in what we 22 said. I was not aware of the fact that it was out until 23 I looked at it earlier today, to be quite honest. 24 THE CHAIRMAN: As I recall Professor de Leval's response, 25 I may be wrong, it was the case that he was not aware 0159 1 that it had been taken out either. 2 MISS GREY: Can you help us as to what your understanding 3 was of the status of the first report when it was faxed 4 through to Bristol? 5 A. I am not sure I understand what you are asking. 6 Q. It has been described as being variously "confidential" 7 or "a draft". What did you understand it to be? 8 A. I understood it was a confidential report which was for 9 the UBHT. 10 Q. And by "confidential", who did you understand it would 11 be circulated to? 12 A. I assumed that that would be up to the UBHT. We were 13 asked by the UBHT, by Mr Wisheart on its behalf, to do 14 the report, and therefore our remit was to send it to 15 them. 16 Q. Did you understand that the first report that you had 17 sent through was, as it were, a working draft that other 18 people might comment on and ask you to revise, or 19 a final version that -- 20 A. I thought that it was a draft. 21 Q. By which you mean what? 22 A. That "this is what we intend to say and we would like to 23 hear your comments". That is what I have done on other 24 reports. 25 Q. If you had that understanding, on what was it based? 0160 1 A. I could not honestly tell you, to be quite honest. I am 2 assuming that that was what we decided at the time, that 3 we would send a draft report. I am sorry, my memory 4 cannot help you in that respect. But that is what 5 I assumed it was: it was a draft report. 6 Q. You were asked to produce a report in a short window of 7 time. Did you have, at that time, any concerns about 8 your remit or brief? 9 A. Indeed. Indeed, as I suggested earlier, people always 10 want these things done yesterday. I personally think 11 I would echo exactly what Marc de Leval said earlier: if 12 I were asked to do it again, I would not accept to do it 13 in that time. 14 Q. Do you in general have any concerns or problems with the 15 practice of reporting on surgical performance by 16 a contemporary or a peer from another unit? 17 A. I do not have a problem with that, no. 18 Q. Why is that, or how can that be an adequate way of 19 investigating one's own peers? 20 A. That is a rather different question, is it not? I do 21 not have a problem with a comment being made by a peer 22 from another surgeon. If you want to make it official 23 and have it on a more formal basis, then I think you 24 have to have a proper review and that is what I think we 25 are going to try and suggest for the future: that such 0161 1 a thing will be ongoing and available. 2 MISS GREY: Sir, I am conscious of the time and Dr Hunter 3 does have to leave promptly in order to catch the only 4 flight back up north. Various difficulties have been 5 caused, as you remarked on, by the fact that not only do 6 we now have more data, but it has not been possible to 7 circulate it. I wonder if, in the light of that, it 8 might be appropriate firstly to ask Dr Hunter to check 9 his papers and to provide to us any further material 10 that he has in relation to this matter; and then, 11 subject to any questions that you the Panel have now, 12 which of course there is I think time for, to reconsider 13 at greater leisure with the assistance of all those 14 other interested parties, whether there are further 15 matters that need to be revisited in the light of the 16 further material now available to the Inquiry. 17 I cannot formally suggest to the Inquiry that my 18 questioning, let alone that prompted by the 19 participation and assistance from other participants, 20 has come to an end today. 21 THE CHAIRMAN: Miss Grey, you have been very helpful. 22 I think the sensible thing here is, rather than engage 23 in questions from the Panel at this point, and conscious 24 of the fact that out of respect for our witness, who may 25 be otherwise under threat of having to spend the night 0162 1 in Bristol -- 2 MISS GREY: That was not my suggestion, sir. 3 THE CHAIRMAN: Not mine either! -- that first of all those 4 whom we heavily rely upon to help us should have 5 an opportunity to see the material that we are now going 6 to be provided with, and equally, that we do. I think 7 frankly we will have to reserve the position as to 8 whether we may indeed have to invite Mr Hunter to come 9 back and talk to us further. I am sure there will be 10 generated questions in writing, and it may well be we 11 will have to see if we can persuade Mr Hunter to come 12 and talk to us again. 13 MISS GREY: In the meanwhile, if I can repeat, Dr Hunter, 14 the invitation to look through your papers and see if 15 you can provide anything further, we would be grateful 16 for that. 17 DR HUNTER: This is the sum total of them. You will let me 18 know what in particular you want? 19 MISS GREY: It may well be if you feel able to leave the 20 file with us, we can make that judgment and return it to 21 you afterwards? 22 DR HUNTER: I think that would be reasonable. 23 MISS GREY: Can I thank you for your attendance. I know you 24 have been waiting throughout the day as I questioned 25 Professor de Leval, and it may be that our difficulties 0163 1 in timing are partly due to that. 2 THE CHAIRMAN: Yes, I echo those thanks, Dr Hunter. Our 3 procedure is straightforward when it works, but 4 sometimes it creates the occasional difficulties. 5 I hope you will not be too inconvenienced by the fact 6 that we may have to carry some matters further. It is 7 very important for us, and it is very important for 8 others who may want to look at things and feed in 9 questions through Miss Grey or whatever. 10 So for today, thank you, and we will be in touch 11 in due course and you will give us, I trust, all the 12 material you have. Thank you. 13 Dr Hunter, given the time-scale, please make your 14 way. 15 Miss Grey, what do you have in terms of telling 16 us, please? 17 MISS GREY: Sir, tomorrow we start with the evidence of 18 Professor Angelini, followed in the afternoon by that of 19 Janet Maher. 20 THE CHAIRMAN: Thank you. 21 MISS GREY: There will also be an application during the 22 course of the day, I understand, by Mr Lissack and no 23 doubt a response from the UBHT. The timetabling of 24 that, sir, I think we will leave for the moment. 25 THE CHAIRMAN: Thank you. It has not been an entirely 0164 1 satisfactory day, but we will see if we can rescue the 2 situation in due course. For the moment, therefore, we 3 reconvene tomorrow at 9.30. We will adjourn now. Good 4 afternoon to everyone, and thank you, Miss Grey. 5 (5.00 pm) 6 (Adjourned until 12th October 1999 at 9.30 am) 7 8 9 10 11 I N D E X 12 13 14 PROFESSOR MARC DE LEVAL (Sworn) 15 Examined by MISS GREY ...................... 2 16 Examined by THE PANEL ...................... 111 17 18 DR STEWART HUNTER (Sworn) 19 Examined by MISS GREY ...................... 114 20 21 22 23 24 25 0165